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It was the aim of the study: to compare the behavioral 
and cognitive effects of pharmacological and behavioral 
therapies in the short-term, clinical treatment of minimal 
brain dysfunction; and, to compare the behavioral and cog-
nitive effects of stimulant (methylphenidate) and 
antidepressant (imipramine) drugs in the short-term, 
clinical treatment of minimal brain dysfunction. 
Twenty-nine boys, ranging in age from 6 through 12 years, 
with the diagnosis of minimal brain dysfunction with hyper-
activity, were randomly assigned to three treatment groups: 
imipramine, methylphenidate, or behavior modification. The 
total time of treatment for each child was 6 weeks. 
For subjects within the imipramine and methylphenidate 
groups, medication dosage was individually titrated by a 
child psychiatrist. (Range: 75- 150 mg/daily of imipramine, 
10- JO mg/daily of methylphenidate.) 
Parents of subjects within the behavior modification 
group individually met with an experimenter l hour per week. 
Behavioral principles were discussed, problem behaviors 
targeted, and behavioral programs devised for implementation 
during the treatment period. 
Subjects assigned to behavior modification were also 
individually seen once weekly. The first part of a session 
focused on behavioral control, following the method of 
behavior rehearsal. Working from problem areas targeted by 
parents, the subjects and experimenter discussed specific 
encounters, and then reenacted these incidents, rehearsing 
alternative, adaptive behaviors. The second part of a ses-
sion was devoted to cognitive control, with training in 
self-directed verbal commands instituted. On tasks of trail 
making, matching pictures, and embedded figures, subjects 
verbally cued themselves to delay and to consider require-
ments before attempting a solution, with reinforcement 
contingent upon responses correct on initial trial. 
For all groups, prior to and following treatment, behav-
ioral and cognitive measures were obtained: parents 
completed a behavior rating scale, the Parent's Question-
naire; teachers completed the School Report, assessing 
behavior and academic achievement; and subjects were 
administered a battery of psychological tests which included 
the Wechsler Intelligence Scale for Children, Wide Range 
Achievement Test, Porteus Maze Test, Bender Gestalt Test, 
Developmental Test of Visual-Motor Integration, and Draw-A-
Person. 
Analysis of the data from teachers' global ratings of 
behavior indicated the superiority of pharmacological 
treatment in comparison with behavioral treatment. Within 
the cognitive area, based on teachers' global ratings of 
academic achievement and the Porteus Maze Test, pharmaco-
logical treatment was again shown superior. Isolating 
specific group effects, contributing to the major portion 
of the variance between pharmacological and behavioral 
treatments was the superiority of methylphenidate to behav-
ior modification. Further research was felt necessary 
concerning the therapeutic comparability or lack of 
comparability of imipramine and behavior modification treat-
ments. 
Between imipramine and methylphenidate treatments, based 
on teachers' ratings of hyperactivity and global ratings of 
both behavior and academic achievement, differential effects, 
in favor of methylphenidate, were suggested. Thus, the com-
parability of imipramine and methylphenidate treatments in 
terms of both behavioral and cognitive effects was felt to 
be in question. 
Results were discussed in terms of the bounds of the 
design, procedure, and measurements. Qualifications were 
noted concerning statistical power, Type I error, the 
relative rather than absolute efficacy of the treatments, 
and the validity of the measurements. 
Application and research implications were presented. 
The need for continued research into the application of 
behavioral programs with MBD children, both independent of 
and in conjunction with pharmacological treatment, was 
stressed, with suggestions provided as to the clinic-based 
and, to a limited extent, school-based implementation of 
such programs. 
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INTRODUCTION 
Writing in the 1902 edition of the British journal Lancet, 
a physician, Dr. G. F. Still, described an "abnormal" 
condition of childhood, a condition that he termed a "defect 
in moral control." It was a condition characterized by rest-
less and fidgety movements, emotional lability, aggressive 
behavior, and the presence of physical stigmata. It most 
frequently affected boys, occurring apart from any general 
impairment of intellect, and without evidence of physical 
disease or environmental impoverishment. 
In retrospect, the condition described bears a marked sim-
ilarity to the syndrome today most commonly known as minimal 
brain dysfunction (MBD) or hyperactivity. 
As defined by a task force under the sponsorship of the 
United States Public Health Service, the syndrome of minimal 
brain dysfunction refers to: 
children of near average, average, or above 
average general intelligence with certain 
learning or behavioral disabilities ranging 
from mild to severe, which are associated 
with deviations of function of the central 
nervous system (Clements, 1966, p. 9). 
While the above definition includes direct reference to 
neurologic functioning, in actuality the question of etiology 
is far from answered, with postulates of causality ranging 
from the exclusively organic to those of a psychogenic nature. 
1 
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The child with minimal brain dysfunction is described as 
manifesting a variety of behavioral, cognitive, and neurolo-
gical symptoms, with no one sign pathognomonic. There are, 
however, certain symptoms which are repeatedly cited in the 
literature, and these in order of frequency are: 
1. Hyperactivity. 
2. Perceptual-motor impairments. 
J. Emotional lability. 
4. General coordination deficits. 
5. Disorders of attention (short attention span, 
distractibility, perseveration). 
6. Impulsivity. 
7. Disorders of memory and thinking. 





9. Disorders of speech and hearing. 
10. Equivocal neurological signs and electroencephalogra-
phic irregularities (Clements, 1966, p. lJ). 
Depending on the author, it is generally estimated that 
from 3 to 10% of primary school-aged children warrant the 
diagnosis of minimal brain dysfunction. It is also estimated 
that minimal brain dysfunction accounts for about 40% of the 
children referred to mental health clinics because of 
behavioral disturbances (Lipman, 1971), and possibly 80% of 
the problems of which certain schools complain (Huessy & 
Gendron, 1970). 
3 
The prognosis for the syndrome was originally thought to 
be benign, with the difficulties disappearing around the 
onset of adolescence. This early view has since been 
revised, and MBD children are now considered to be at risk 
in terms of their later behavioral and cognitive functioning. 
Thus, given the estimates of prevalence and the prognostic 
implications, preventing and minimizing the effects of mini-
mal brain dysfunction have become major health concerns. 
The literatures of education, neurology, pediatrics, 
psychiatry, and psychology abound with articles on the 
treatment of the MBD syndrome. While each of the disciplines 
offers its unique treatment perspective, it is pharmacology 
which currently occupies the front line of therapy. Dating 
back to Bradley's (l9J7) work with benzedrine, pharmacologi-
cal treatment has grown to the point at which it is estimated 
that some JOO,OOO children are now receiving medication 
(Wiens & Anderson, 1971). 
Recent literature reviews report that of the drugs typi-
cally employed in the treatment of minimal brain dysfunction, 
central nervous system stimulants are preferable. There are, 
however, reservations with regard to the use of stimulants. 
Foremost are the effects of the medication on physical devel-
opment, side effects of treatment, and concerns of addiction 
potential. There have been a few reported studies suggesting 
the usefulness of tricyclic antidepressant drugs in 
treatment, but as yet the effectiveness of these agents has 
not been directly compared with that of the stimulants. 
As search for alternative pharmacological treatment con-
tinues, there is also need for the development of effective 
non-drug treatments. Questions remain as to the long-term 
influence of medication; also there are some children who 
are nonresponders to pharmacological treatment, and other 
instances when medical or parental prohibition precludes 
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drug treatment. The behavior modification literature reports 
non-drug treatment of behavioral and cognitive problems asso-
ciated with minimal brain dysfunction. However, there have 
been no direct comparisons of the behavioral and pharmacolog-
ical therapies in clinical treatment. 
It is thus the aim of the present study: 1. to compare 
the behavioral and cognitive effects of pharmacological and 
behavioral therapies in the short-term, clinical treatment of 
minimal brain dysfunction; and 2. to compare the behavioral 
and cognitive effects of a stimulant drug, methylphenidate 
(trade name Ritalin) and an antidepressant drug, imipramine 
(trade name Tofranil) in the short-term, clinical treatment 
of minimal brain dysfunction. 
Following this introductory section, the dissertation is 
divided into five chapters. The first chapter provides a 
description of minimal brain dysfunction, surveying the areas 
of terminology, symptomatology, prevalence, etiology, and 
prognosis. In the second chapter, treatment is discussed, 
with the review primarily considering three approaches, 
5 
stimulant and antidepressant drug therapy, and behavior 
modification. In the final three chapters, the methodology, 
results, and discussion, respectively, of the present study 
are presented. 
As discussed in Chapter l, terminology is an issue within 
the literature, with one of the primary areas of conflict 
concerning the use of the terms "minimal brain dysfunction" 
and "hyperactivity." For purposes of consistency, the 
author has chosen to retain the "minimal brain dysfunction" 
terminology except in the presentation of the behavioral 
treatment literature, or unless a specific behavioral dimen-
sion such as activity level or attention span is under 
consideration. In the description of the sample, Chapter J, 
the medical diagnosis is specifically designated as "minimal 
brain dysfunction with hyperactivity," emphasizing activity 
level as being one of the primary selection criteria. 
CHAPTER l 
REVIEW OF THE LITERATURE -I: DESCRIPTION 
OF MINIMAL BRAIN DYSFUNCTION 
Diagnostic Issues 
In an area fraught with conceptual disparities and 
empirical inconsistencies, it is perhaps not surprising that 
even the legitimacy of the minimal brain dysfunction diagno-
sis is a subject for debate. 
There is concern that the minimal brain dysfunction label 
has become a wastebasket diagnosis, a label assigned arbi-
trarily whenever a child manifests any significant 
psychological symptom, fails to learn, or just generally 
fails to meet the expectations of his parents and/or teachers 
(Paine, 1968; Schwartz, Pizzo, & McKee, 1971; Twitchell, 
1971). There are those who fear that the diagnosis may be 
applied to the bored but bright child, or to the child who 
cannot or will not comply with the unnatural demands of edu-
cational institutions to be still and silent (Gallagher, 
1970). 
Fish (1971), in reviewing the literature on brain disor-
ders in children, found that minimal brain dysfunction and 
hyperactivity, once regarded as nonspecific disorders, have 
now replaced diagnosis. Several investigators have 
indicated that the assignment of diagnostic status to minimal 
brain dysfunction is premature for basic issues await 
6 
7 
clarification. Quantitatively and qualitatively, data on 
the various facets of "normal" child development are lacking 
(Moore & Welcher, 1971). The possibility of socioeconomic 
and ethnic variability of symptoms has not been explored 
(Werry, l968a). It is not known if various cognitive diffi-
culties thought to be peculiar to the MBD child are 
characteristic of a wider spectrum of psychologically dis-
turbed children (Werry, Weiss, Douglas, & Martin, 1966). 
Assuming that the normal-abnormal line can be drawn for 
individual behaviors, it is still unclear what behaviors are 
the defining parameters of the MBD child. As Wender (1971) 
asks, is the hyperactive and distractible child without a 
learning disability to be considered as MBD? Denhoff, Davids 
and Hawkins (1971) reported that ratings of hyperactivity by 
teachers and parents did not correlate significantly. In 
diagnosis, then, by whose criteria is the determination of 
minimal brain dysfunction to be made? 
Although basic diagnostic issues may still be in question, 
Keogh (1971) writes that parents and professionals do know an 
MBD child when they see him. Empirical support for this con-
tention comes from several sources. Stewart (1970) found 
that as reported by parents, MBD and control children did dif-
fer significantly on behavioral questionnaires, while 
Campbell, Douglas, and Morgenstern (1971) reported signifi-
cant differences based on classroom observation. Conners 
(1970) and Werry, Minde, Guzman, Weiss, Dogan, and Hoy (1972) 
have been successful in differentiating groups of MBD and 
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neurotic children. In longitudinal observations covering 10 
years, hyperactivity per se has been shown to be a stable 
behavioral dimension (Battle & Lacey, 1972). 
Given that the behaviors associated with the MBD child, 
behaviors such as hyperactivity, distractibility, and 
lability, are recognizable, troublesome, and apparently 
incompatible with school demands (Schrager & Lindy, 1970), a 
question remains as to the "elevation" of these behaviors to 
the status of a syndrome. In other words, with the seemingly 
disparate clinical pictures often presented by MBD children, 
is there, in fact, justification in grouping these children 
together, justification in assigning to all the diagnosis of 
minimal brain dysfunction? 
As noted by Campbell et al. (1971), it has been assumed, 
without empirical evidence, that behavioral, cognitive, and 
neurological symptoms covary. However, a factor analytic 
study by Werry (l968b) sampling lOJ children diagnosed as 
MBD found 10 basically unrelated dysfunctions; and each dys-
function tended to be comprised mainly of measures from only 
one source, such as psychological, neurological, or 
psychiatric data. 
Expressing the views of those who oppose the syndrome 
approach, Twitchell (1971) suggests that given the ill-
defined concept of minimal brain dysfunction and its 
essentially unrelated parameters, it would be wise to abandon 
labeling and concentrate on the problems of the individual 
child. Advocates of the syndrome approach do not dispute 
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these criticisms, but nonetheless do contend there is value 
in the syndrome concept. Rather than stressing the hetero-
geneity underlying the minimal brain dysfunction concept, 
these authors have chosen to emphasize the clustering of 
certain symptoms (Clements, 1966; Wender, 1971). Kaspar, 
Millichap, Backus, Child, and Schulman (1971) found that 
although behavioral correlates were not convergent, they were 
parallel, with the setting and nature of the stimulus 
materials being central to the syndrome concept. Thus, 
activity and distractibility did correlate significantly 
among structured tasks of visual or auditory functioning, but 
not necessarily between these areas. 
Also in defense of the syndrome status of minimal brain 
dysfunction, research and treatment considerations are 
offered. Given the somewhat unwieldy nature of the subject 
matter, the minimal brain dysfunction label is felt to focus 
research, and also to orient the clinician to the multi-
treatment needs of these children (Katz, 1972; Lesser (1970). 
Terminology 
Along with questions as to the existence of the MBD child 
and the MBD syndrome, the subject of terminology is also con-
flicted. At present, the terms "minimal brain dysfunction" 
and "hyperactivity" appear to have gained the widest 
acceptance. It may be noted that in addition to these two, 
at least JS other terms, such as "minimal brain damage," 
"cerebral damage," "hyperkinesis," and "learning disability," 
used to describe the syndrome and its various subcategories 
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have been identified (Clements, 1966). 
"Minimal brain dysfunction," in contrast to "hyperactiv-
ity" or other of the terms stressing behavioral aspects, has 
the advantage of emphasizing the multiple developmental 
dysfunctions of the syndrome (Fish, 1969) rather than a 
single symptom which need not in fact be present (Huessy, 
1967). Also, it is felt that use of the term, in emphasiz-
ing the organic hypothesis, may tend to make the parents 
more understanding of the child, and may also ameliorate 
parental guilt (Clements & Peters, 1962). 
Those citing objections to the "minimal brain dysfunction" 
terminology indicate that, to begin with, the problem itself 
is certainly not "minimal," and that in another sense, there 
has been to pathological documentation to warrant an organic 
interpretation of "minimal." Likewise, without anatomical 
identification, "brain" and "dysfunction" are terms used 
without justification (Cruickshank, 1972; Friedman, 1969). 
"Hyperactivity," a descriptive term, has the advantage of 
bypassing the etiologic question (Eisenberg, 1972; Marwit & 
Stenner, 1972). Furthermore, "minimal brain dysfunction" is 
seen as having little diagnostic value, being devoid of edu-
cational or psychological implications (Friedman, 1969). 
The emphasis on organicity, the argument continued, serves 
only to produce a therapeutic nihilism and to allow the pub-
lic schools to exclude children so labeled (Werry, l968a). 
At face value, the terminology issue may appear just a 
question of semantics. There are authors, however, who 
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place semantic disparity at the core of the many inconsis-
tencies found in the literature. While "minimal brain 
dysfunction" and "hyperactivity" are not considered mutually 
exclusive, they reject their synonymity, hypothesizing that 
contradictions in research are artifacts created by applying 
the same terms to vastly different groups of children (Birch 
& Bortner, 1968; Fish, 1971). 
Whether this be or not, ln most of the literature the 
usage of the terms, unless otherwise specified, is essential-
ly synonymous. For example, Wender (1971), favoring "minimal 
brain dysfunction," recognizes hyperactivity as a salient 
attribute of most MBD children. Werry and his associates 
(Werry, 1968b; Werry et al,, 1966), preferring "hyperactivity," 
indicate that as most of their subjects have associated 
behavioral, cognitive, and neurological disorders, it is 
reasonable to conclude that the majority do not differ from 
those elsewhere described as MBD. 
Symptomatology 
As indicated in the above discussions of diagnosis and 
terminology, the actual parameters of minimal brain dysfunc-
tion continue to be in question. A number of generalizations 
have been made concerning behavior and cognitive functioning, 
generalizations which are frequently offered without 
empirical support, and which are at times contradictory. 
Millichap (1968) writes that the heightened motor activity of 
the MBD child is usually confirmed without difficulty in the 
clinician's office, whereas Stewart (1970) and Wiens and 
Anderson (1971) indicate that when under tension or in 
strange situations, activity may be subdued, and thus no 
behavioral symptoms may be apparent upon interview. 
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Clements and Peters (1962) rely on patterns of subtest 
scatter on the WISC and other "organic" indicators in the 
psychological test battery in their diagnosis. Paine (1968) 
finds psychological test irregularities among the most 
impressive findings. Conners (1967), however, cites the 
myth of patterns, stating that no battery of psychological 
tests is, at present, adequately standardized to insure 
discrimination of minimal brain dysfunction from psychogenic 
or cultural deficits. 
Behaviorally, based on parent and teacher report, MBD and 
normal children have been differentiated on dimensions such 
as activity, anxiety, distractibility, aggression, and 
social adjustment (Conners, 1970a; Weiss, Minde, Werry, 
Douglas, & Nemeth, 1971). Most of the observational data, 
however, relate specifically to hyperactive behavior. 
In defining hyperactivity, the distinction has been made 
between quantitative (total amount of movement) and qualita-
tive (situational appropriateness and structure of movement) 
dimensions (Werry, 1968a). Based on actometer recordings, 
both Pope (1970) and Kaspar et al. (1971) found no 
difference in the total motor activity of MBD and control 
children in free play situations. Pope, however, did report 
that the MBD subjects traversed more grid areas, spent a 
greater amount of time uninvolved with any toy, and made a 
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greater number of contacts with the toys, each of a shorter 
duration, than the control group. 
In contrast to the undirected situation of free play, 
Pope (1970) found that when given instructions to refrain 
from movement, the activity level of the MBD subjects was 
greater than that of the control group. Kaspar et al. (1971) 
also reported this difference given the structured situation 
of psychological testing. Sykes, Douglas, Weiss, and Minde 
(1971), measuring activity by seat cushions, likewise found 
that MBD children were more restless than controls during a 
testing session, and that restlessness, while increasing 1n 
both groups during a second session, had increased at a 
faster rate for the MBD subjects. 
Observation would thus seem to indicate, as Kaspar et al. 
(1971) conclude, that the effect of minimal brain dysfunction 
is not to increase the amount of activity the child generates 
in a free situation, but rather to make it more difficult for 
him to reduce his activity level when such reduction is 
expected or required, pointing to a deficiency in control or 
inhibitory processes. 
While there appears to be at least verbal agreement con-
cerning the behavioral difficulties of the MBD child, the 
subject of cognitive functioning is somewhat conflicted and 
inconsistent. The terms "minimal brain dysfunction" and 
"learning disability .. have at times been used synonymously 
(Tarnopol, 1971), but their identity is not necessarily sup-
ported on the basis of the traditional psychological test 
battery. 
Various studies attest to the superiority of control in 
comparison with MBD children on a number of standard 
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measures of intellectual, academic, and perceptual-motor 
functioning. The specific nature of these differences is 
not, however, consistent across studies. For example, 
Stevens, Boydstun, Dykman, Peters, and Sinton (1967) reported 
that MBD and control groups differed significantly, in favor 
of the latter, on the WISC Verbal and Full Scale scores, 
while Wikler, Dixon, and Parker (1970) indicated that 
Performance and Full Scale scores were lower in their MBD 
subjects. 
A study by Palkes and Stewart (1972) reported that MBD and 
control groups differed significantly on intelligence, 
achievement, and perceptual tests, all differences in favor 
of the control children. However, when scores were adjusted 
for Full Scale intelligence, neither achievement nor percep-
tual tests distinguished between the two groups 
significantly. It was concluded that while MBD children may 
perform less well on tests of intelligence, they do learn at 
a normal rate for their measured intelligence, and thus 
doubt is cast on the assumptions of underachievement and 
perceptual-motor handicap in this group. 
Rather than a difference in intellectual ability or 
specific cognitive skills, Campbell ~ al. (1971) hypothe-
sized that the general style or approach to problem solving 
of MBD children may pervade and be sufficient to explain their 
poorer performance. Comparing MBD and control samples on the 
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cognitive dimensions of reflection-impulsivity, constricted-
flexible control, field dependence-independence, and automa-
tization, they found that: 
the hyperactive child is more likely to respond 
impulsively without evaluating the response pos-
sibilities ..•. is less apt to monitor his 
behaviour and inhibit incorrect responses ..•• 
tends to be more easily drawn by the most 
obvious and compelling aspects of the stimulus 
field .•.• (and) when the task requires rapid 
response rates, he is slower than the normal 
child I I I (pI 65) I 
The view of a global rather than specific cognitive 
deficit has been expressed by several other investigators, 
with both stages of information processing (acquisition and 
decision making) cited in explanation of such global deficit. 
At the stage of input, it is hypothesized that attentional 
defects disrupt the accurate acquisition of information. 
Freibergs and Douglas (1969) found that MBD in comparison 
with control children did more poorly on a concept attainment 
task under conditions of partial reinforcement: however, 
there was no difference between groups under continuous rein-
forcement. The authors suggested that continuous 
reinforcement counters distractibility and restlessness, 
increases motivation, and thus draws attention to the task 
for MBD subjects. Keogh (1971), in reviewing this study, 
offers an alternative explanation, considering that continu-
ous reinforcement may not only serve to increase attention, 
but also to reduce the number of possible hypotheses to be 
dealt with in problem solving. 
Sykes et al. (1971) hypothesized that the greater number 
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of errors of omission of their MBD subjects in comparison 
with the control on a continuous performance test indicated 
an impairment in sustained attention. Since the difference 
between groups in both errors of omission and commission 
was greater at a slower interval of presentation, it was also 
suggested that on a decision making dimension, MBD children 
are more prone to impulsive responding, while the normal 
child evaluates each stimulus and thus inhibits incorrect 
responses. 
Whatever the cognitive deficit of the MBD child, specific 
or global, input or central processing, there is still the 
question of whether such deficit is the direct or indirect 
result of minimal brain dysfunction. Does the behavioral 
constellation of minimal brain dysfunction, especially hyper-
activity and distractibility, disrupt cognitive functioning? 
Or are the difficulties in learning more directly the result 
of independent cognitive disorders (Keogh, 1971; Werry, 
l968a)? 
Werry (l968a) comments that: 
it is possible to hypothesize that the hyper-
active child as ordinarily seen with his 
combination of learning and other behavioral 
difficulties represents a pseudosyndrome, the 
result of selective screening •••. Such a 
question is, however, largely academic, since, 
from the point of view of the clinician, the 
average hyperactive child in trouble can be 
expected to have associated learning and 
behavioral disorders (p. 585). 
Keogh (1971) concludes that it seems safe to say that MBD 
children often have learning problems. However, neither the 
particular educational skills affected nor the specific 
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mechanisms responsible have been verified. Thus, one cannot 
conclude that all MBD children will be learning disabled, 
and any assumption of cognitive impairment must be 
established independently. 
Prevalence 
Generally, the rates of prevalence for minimal brain dys-
function are largely impressionistic, with estimates ranging 
between J - 10% of the grade school population (Lipman, 1971; 
Paine, 1968). The variability in rates is attributable in 
part to differences in diagnostic criteria, and also to dif-
ferences in the children targeted. For example, Conrad, 
Dworkin, Shai, and Tobiessen (1971) place the prevalence at 
J - 5% for middle class children, and lo% for lower class 
children. Stewart (1970) estimated that 4% of suburban grade 
school children meet the criteria, while Huessy and Gendron 
(1970) report that for inner city slum school populations, 
impressions run as high as 4o% of the students. 
Based on clinical referral rates, the ratio of boys to 
girls ranges from estimates of 4 or 5:1 (Huessy, 1967; 
Lipman, 1971), to as high as 9 or 10:1 (Werry, l968a); Wiens 
& Anderson, 1971). 
Etiology 
In the early 1920s, following an encephalitis epidemic, 
clinicians recognized a postencephalitic behavior disorder 
in those children who had recovered from the acute phase of 
the illness. Behavioral sequelae included hyperkinetic and 
restless activity, emotional lability, disobedience, 
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quarrelsome and abusive behaviors, and a decline in academic 
performance (Ebaugh, 1923). Given the similarity of these 
symptoms to those of the MBD child, it is perhaps not 
surprising that theories of organic etiology dominate the 
minimal brain dysfunction literature. 
The list of organic considerations is extensive, ranging 
from hypotheses of structural damage or dysfunction to 
explanations entailing more subtle biochemical variations. 
Circumstances of genetic transmission, random intrauterine 
variation, pre- and paranatal trauma, and other factors 
presently unknown, have all been cited as plausible events 
leading to innate dysfunctions, constitutional variability, 
or maturational delay (Lesser, 1970; Lipman, 1971; Millichap 
& Fowler, 1967; Wender, 1971). 
Since there has been no pathological documentation of 
brain damage or dysfunction, neither diffuse nor localized, 
theories of organic etiology are inferential, stemming mainly 
from the neurological status of MBD children. 
In a study of MBD and control subjects by Stewart, Pitts, 
Craig, and Dieruf (1966), no significant difference was found 
in medical history suggestive of probable brain injury. The 
authors concluded, however, that the prevalence of delayed 
speech development, current speech problems, poor coordina-
tion, and strabismus in MBD children suggests that brain 
dysfunction rather than primarily psychological factors is 
often the basis for the syndrome. 
In a study by Werry et al. (1972), again, no difference was 
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found in medical history (birth records), nor in major 
neurological signs or EEG recordings of MBD and control sub-
jects. However, an excess of neurological soft slgns was 
reported in MBD subjects as compared to both normal and 
neurotic children. 
Boydstun, Ackerman, Stevens, Clements, Peters, and Dykman 
(1968) compared the physiological levels (heart rate, muscle 
reaction, and skin resistance) of MBD and control children 
during a tone discrimination task. The groups did not differ 
in the resting state, but the controls were more physiologi-
cally reactive during training. It was hypothesized that 
deficiencies related to cortical arousal structures could 
explain the performance of the MBD group. 
Dykman, Walls, Suzuki, Ackerman and Peters (1970) compared 
the performance of hyperactive, hypoactive, normoactive 
samples on a telegraph pressing task. The authors concluded 
that the slower response times and greater error scores of 
the hyper- and hypoactive groups, suggesting slower informa-
tion processing, were supportive of the Boydstun et al. (1968) 
theory of defective cortical arousal. They added that while 
the evidence warranted neurological interpretation, a primary 
organic explanation was not necessarily indicated for neural 
maturation also depends upon experience, and thus 
neurological status can plausibly be viewed as a reactive 
rather than causal state. 
Huessy and Gendron (1970), in studying the stability of 
the behavioral constellation of minimal brain dysfunction, 
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found that the constellation was stable in only 1/J to 1/2 
of the group originally so identified; furthermore, other 
children who had not shown symptoms previously were 2 1/2 
years later reported to be hyperactive. The authors con-
cluded that, based on the instability of the behavioral 
constellation, a purely organic hypothesis appears untenable. 
In a discussion of the psychogenic ("reactive to environ-
mental or inner neurotic stress") determinants of minimal 
brain dysfunction, Wender (1971, p. 48) considers two pos-
sible subgroupings, a purely reactive form and a 
privation-produced form. In support of reactive etiology he 
finds evidence from clinical reports that hyperactivity can 
be increased by increasing psychological stress, and in turn, 
decreased by decreasing such stress. Both human and animal 
studies have also indicated that early environmental depriva-
tion can generate IVIBD-like characteristics such as heightened 
activity and impaired cognitive functioning. However, since 
not all children subjected to psychological and environmental 
stress or interpersonal privation develop MBD behavior pat-
terns, Wender suggests that biological predisposing 
characteristics must exist, and interact in some manner with 
psychogenic determinants. 
Battle and Lacey (1972), in a nonclinical longitudinal 
study, did report, in contrast to Huessy and Gendron (1970), 
hyperactivity to be a relatively stable dimension over 10 
years, but also found that on the basis of observational and 
interview data, mothers oT high activity children were 
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critical, disapproving, and severe in punishment. They con-
cluded that from the earliest years, hyperactivity is 
negatively received by the mother, and thus parental and 
environmental factors may possibly exacerbate the condition. 
At present, organic, psychogenic, and interactional hypo-
theses all remain unestablished. The prevailing view, 
however, does hold that although obscure, etiology is most 
plausibly organic (Weiss et al., 1971). 
Prognosis 
In their landmark article, Laufer and Denhoff (1957) com-
mented that minimal brain dysfunction was a situation which 
in the course of the normal maturational process was overcome. 
The place of treatment, therefore, was to prevent the 
development of psychological consequences prior to that 
point. Writing at a later date, Paine (1968) held a somewhat 
similar position, stating the long-range prognosis to be 
relatively favorable, with adult adjustment basically satis-
factory. 
With the publication of a retrospective study by Menkes, 
Rowe, and Menkes (1967), the complacency regarding prognosis 
was tempered. From child psychiatry records dating back 
14-27 years, the authors were able to contact 14 of the 18 
subjects adjudged to meet the criteria for minimal brain dys-
function. At the time of original referral, treatment of 
this group had varied, ranging from a single clinic visit to 
ongoing counseling support for a period of 7 years. None of 
the subjects had received pharmacological therapy. Follow-up 
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information obtained from clinical interview, telephone con-
tact, or parental report revealed that of the 14 subjects: 
4 were institutionalized with a psychiatric diagnosis; 2 
were considered retarded and were residing with their fami-
lies; 8 were self-supporting, but of these 8, 4 had at some 
point been hospitalized or incarcerated; of the ll subjects 
the authors were able to interview clinically, 8 still had 
evidence of neurological dysfunction, The authors them-
selves cautioned in regard to conclusions that, in addition 
to the small size of the sample, the findings could reflect 
diagnostic errors of inclusion rather than the natural 
history of the syndrome. 
Suggesting that minimal brain dysfunction may be the pre-
cursor of adult psychiatric disorders are other retrospective 
studies. Quitkin and Klein (1969), sampling adolescent and 
young adult psychiatric patients, found that a case history 
of childhood hyperactivity was a strong predictor of adult 
"impulsive-destructive" disorder. A different childhood pat-
tern was reconstructed for an "awkward-withdrawn" group. 
Rochford, Detre, Tucker, and Harrow (1970), studying 
hospitalized and day patients, found that a significantly 
greater percentage of neurological abnormality was found in 
the patient group as compared with control subjects, and that, 
in turn, neurological findings were more often present in 
patients with histories of behavioral and psychological dif-
ficulties associated with minimal brain dysfunction. 
Retrospective studies, and especially those without control 
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data, are of inconclusive prognostic value at best. Within 
the past few years, longitudinal studies have begun to be 
available. 
Stewart (1970) presented 5 year follow-up data on 45 
teenagers who previously had been diagnosed as MBD. In 
interviews with parents, it was reported that of the 45: 5 
were more or less free from the original symptoms; 26 were 
somewhat improved; and 14 were not improved or worse. Most 
subjects were still reported to be restless, with poor con-
centration, school performance, and self-esteem. In fact, 
there was felt to be an increase in impatience, irritability, 
antisocial behavior, and resistance to discipline. Inter-
views with the teenagers revealed that many found it hard to 
study and were not interested in school. The author, while 
noting the need for a control group, did feel that compared 
with baselines from other studies, normal teenagers do not 
have the extent of the problems manifested by his sample. 
Although Stewart did not indicate what, if any, treatment 
this sample had received, in another article (Mendelson, 
Johnson, & Stewart, 1971) follow-up data was presented on 8J 
teenagers, 92% of whom had received stimulant drugs, and 
most of whose parents had received counseling. This sample 
did presumably include the 45 subjects from the 1970 study, 
and reached essentially the same conclusions. 
A 5 year follow-up evaluation of MBD children, with 
control data, has recently been published in a series of 
articles (Cohen, Weiss, & Minde, 1972; Minde, Lewin, Weiss, 
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Lavigueur, Douglas, & Sykes, 1971; Weiss et al., 1971). All 
64 subjects had previously received some form of drug treat-
ment--dextroamphetamine, methylphenidate, or chlorpromazine. 
In addition, 1~% had participated in remedial programs in 
addition to regular schooling, and lo% of the families had 
received counseling. Based on parents' and teachers' reports 
and classroom observation, it was found that hyperactivity, 
per se, although still present in Jo% of the sample to some 
extent, was no longer the chief complaint, Other major 
handicaps did persist, however. Parents listed distractibil-
ity as a major concern, with social adjustment and low. 
self-esteem also frequently noted. From teachers' ratings, 
it was found that MBD and control subjects did differ signif-
icantly, with difficulties in restlessness, concentration, 
and aggression, although somewhat diminished with age, still 
remaining. Academically, only 20% of the MBD group had not 
repeated a grade. Even when the effect of intelligence was 
controlled, their achievement was inferior to the control 
subjects. On psychological testing, there were significant 
differences in intellectual functioning, evenness of cogni-
tive profiles, and in cognitive style. 
In summarizing the state of prognostic research, 
Eisenberg (1972) emphasizes that to date, no careful follow-
up of a comprehensively and continuously treated group has 
been reported. Until such data are available, it is not 
known if the negative prognostic implications found in the 
literature are the necessary consequences of the basic syn-
drome. 
Summary 
Of basic issue is the legitimacy of the minimal brain 
dysfunction diagnosis itself. There is concern that the 
label has become a wastebasket diagnosis, assigned 
arbitrarily whenever a child deviates from the expected 
norm. The opposing view holds that parents and profes-
sionals do know an MBD child when they see him, and that 
empirically, MBD, neurotic, and normal children have been 
found to differ significantly. 
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As with diagnosis, the issue of terminology is also 
conflicted. Currently, the terms "minimal brain dysfunc-
tion" and "hyperactivity" have gained the widest acceptance, 
with benefits cited regarding the use of each. While the 
usage of the terms in the literature is essentially synony-
mous, semantic disparity is hypothesized by some to be at 
the core of the many inconsistencies found in research. 
With regard to behavioral symptomatology, based on 
parent and teacher report, MBD and normal children have been 
distinguished on dimensions such as activity, anxiety, 
distractibility, aggression, and social adjustment. Most 
of the observational data, however, relate specifically to 
hyperactive behavior, and seem to indicate that the effect 
of minimal brain dysfunction is not to increase a child's 
activity in a free situation, but rather to make it more 
difficult for him to reduce activity when such reduction is 
required. 
Concerning the cognitive symptomatology of MBD children, 
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assumptions of underachievement and perceptual-motor handi-
cap have been challenged. Rather than a difference in 
specific cognitive skills, some authors have hypothesized 
deficits in the MBD child's global approach to problem 
solving. It is concluded that MBD children often have 
learning problems; however, the particular skills or mecha-
nisms involved await verification, and thus, any assumption 
of cognitive impairment must be established independently. 
Prevalence rates for minimal brain dysfunction are 
largely impressionistic, with estimates ranging between 
3 - lo% of grade school children, with the ratio of boys to 
girls placed at 4:1 to as high as 10:1. Variability in 
rates is partly attributable to differences in diagnostic 
criteria, and also to differences in the populations tar-
geted. 
The list of etiologic considerations for minimal brain 
dysfunction is extensive, with postulates of causality 
ranging from the exclusively organic to those of a psycho-
genic nature. While there has been no pathological 
documentation of brain damage or dysfunction, the prevailing 
view, based on the neurological status of MBD children, does 
hold that etiology is most plausibly organic. 
On the basis of retrospective and recently available 
follow-up studies, MBD children have been found to be at 
risk in terms of behavioral and cognitive development. How-
ever, to date, data based on a comprehensively and 
continuously treated group are not available, and thus it is 
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still not known if negative prognostic implications are the 
necessary consequences of the basic syndrome. 
CHAPTER 2 
REVIEW OF THE LITERATURE -II: TREATMENT 
OF MINIMAL BRAIN DYSFUNCTION 
Treatment recommendations for the MBD child and/or his 
family include: 
Special school, special class, or additional 
training within a regular class. , . , 
Medication by the pediatrician, neurologist, 
or by the clinic psychiatrist .. , . 
Developmental optometric training·- for 
visual evaluation and visual-motor training 
in areas of deficit, , .. 
Individual or group counseling or psychother-
apy for the child when indicated •.•. 
Parents join appropriate associations .. 
Recreational programs including specific 
gross and fine visual-motor activities .• . . 
Parent counseling groups (Millman, 1970, pp. 
95-96). 
A consideration of each modality is beyond the scope of 
this review, the focus of which is limited to the pharma-
cological, stimulant and antidepressant drugs in particular, 
and behavioral treatment approaches. Regarding the 
remaining approaches, for purposes of this review, suffice 
it to say that currently the empirical evidence necessary 
to accept or reject specific programs is limited (Fine, 
1970), with the greatest amount of success of any one method 





It is estimated that JOO,OOO MBD children are currently 
receiving medication, with stimulant drugs being the pre-
scription for 200,000 of these (Wiens & Anderson, 1971). 
Another group of drugs, the phenothiazines, have been 
reported useful in treatment. However, most studies show 
the phenothiazines inferior to the stimulants, finding 
clinical reports of improvement mixed, and the laboratory 
reports indicating, if anything, a slight deterioration in 
cognitive functioning (Wender, 1971; Werry, 1968a, 1970). 
A group of drugs definitely contradicted are the barbituates 
as they serve to aggravate the syndrome, making the child 
even more hyperactive and disorganized (Wender, 1971; 
Werry, 1968a). 
Stimulant Drug Treatment 
Summary statements of the effectiveness of stimulant 
drugs are somewhat discrepant, with effectiveness estimates 
generally placed somewhere between 1/2 - 2/J improvement 
(Department of Health, Education, and Welfare, 1971), or 
2/J - J/4 improvement (Eisenberg, 1972) of children treated. 
In a literature review, Millichap and Fowler (1967) reported 
wide differences from study to study in percentage improve-
ment. Surveying six studies with methylphenidate, 
improvement ranged from 70 to 90%, deterioration from 0 to 
1% of the cases, with the combined rates being 83% improved 
and 1% worse. In nine studies with amphetamines, 
improvement rates ranged from 40 to 100%, deterioration from 
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3 to Jo%, with combined rates of 69% improved and 11% worse. 
Based on efficacy and toxicity, the authors conclude methyl-
phenidate to be of choice, a view similarly held by a number 
of investigators. 
As a point of comparison, it may be noted that placebo 
improvement is typically reported at approximately JJ%, 
although depending on the measure used, rates as high as 67% 
have been reported (Knights & Hinton, 1969). 
Approaches to the study of the behavioral and cognitive 
effects of methylphenidate may be divided into two, the 
clinical method and the laboratory method. In the clinic, 
dosage is typically individually determined for each subject 
and medication is administered by the parent over a period 
of 4-12 weeks. Pretreatment and posttreatment measurements 
include parents' and teachers' ratings and a standard 
battery of psychological tests. The laboratory method, in 
contrast, generally employs a fixed, single dosage 
administered by staff. Testing occurs at a predetermined 
interval following ingestion, and measurements are usually 
more atomistic, being obtained from automated instrumenta-
tion or direct observational procedures (Werry, 1970). 
Both clinical and laboratory studies have been more con-
sistent in finding evidence of positive behavioral in 
contrast to cognitive change. In controlled investigations 
of methylphenidate and placebo treatments, Weiss, Minde, 
Douglas, Werry, and Sykes (1971) found methylphenidate to be 
superior based on parents' global ratings of behavioral 
31 
improvement, and Sprague and Christensen (1972) reported 
significant differences based on teachers' ratings of con-
duct, distractibility, and hyperactivity. Similarly, based 
on parents' and teachers' ratings, numerous other studies 
have reported the superiority of methylphenidate in compar-
isons with placebo (Conners, 1971; Conners & Rothschild, 
1968; Werry, 1970), 
In classroom observation, methylphenidate has been shown 
to reduce isolation, produce higher percentages of on-task 
behavior, increase both teacher- and pupil-initiated 
positive contact, and decrease pupil-initiated noise and 
negative interaction (Sprague, Barnes, & Werry, 1970; 
Sprague, Werry, Greenwald, & Jones, 1969; Werry, 1970). In 
laboratory measurement, methylphenidate has been found sig-
nificantly better than placebo in reducing seat activity 
(Sprague et al., 1970; Sprague & Christensen, 1972; Werry, 
1970). 
The evidence for behavioral change has not always been 
consistent from study to study. For example, Knights and 
Hinton (1969) found that teachers' ratings, although in the 
right direction, did not differ significantly between 
methylphenidate and placebo groups; Millichap, Aymat, 
Sturgis, Larsen and Egan (1968) and Sprague and Christensen 
(1972) reported no significant differences based on parents' 
reports. Reduction in seat activity was not found by 
Sprague et al. (1969). While positive results, based on 
observation, have been reported for some deviant classroom 
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behaviors, other behaviors such as out of seat and physical 
contact have not shown improvement (Sprague et al., 1969, 
1970). 
Werry (1970) and Sprague and Werry (1971), reviewing the 
research on the behavioral effects of methylphenidate, 
indicate that significant effects are difficult to obtain 
in a single study due to the large error variance of the 
measures and the multivariate determinants of drug response. 
They conclude, however, that while findings have not always 
been significant, they are consistent in indicating the 
superiority of methylphenidate to placebo, an indication 
which becomes even stronger when the results of a number of 
studies are considered. 
In addition to behavioral improvement, there are reports 
of changes in cognitive functioning (intellectual, academic, 
and perceptual) based on standard psychological testing. 
However, in comparison with the evidence for behavioral im-
provement, findings of cognitive improvement have been less 
consistent. For example, comparing methylphenidate and 
placebo groups, Knights and Hinton (1969) reported a 
significant improvement, favoring the methylphenidate sub-
jects, on the WISC Performance Scale. Conners (1972) and 
Weiss et al. (1971), however, found the Verbal score but not 
the Performance to be significantly improved with treatment. 
Conners (1972), in addition, reported significant differences 
on the Bender and Draw-A-Person, but Weiss et al. (1971) 
failed to obtain similar findings. As with the research on 
33 
cognitive deficit presented in Chapter 1, there is a failure 
to replicate the findings of cognitive improvement from 
study to study. 
Based on the lack of consistency or specificity of cog-
nitive improvement, Weiss et al, (1971) suggest that any 
positive effect of methylphenidate is an indirect one, 
possibly the consequence of improved attention. Having 
reacher similar conclusions, several investigators have sug-
gested that finer, more discrete measures of cognitive 
functioning or style are needed since the traditional test 
measures are too global, and thus insensitive to drug effects. 
Sykes et al. (1971) hypothesized that measures such as 
the WISC Digit Span and Coding subtests, in possibly not 
requiring sustained attention, may therefore not reflect 
momentary lapses in attention, Using a continuous perform-
ance test, they did find methylphenidate to improve the 
performance of subjects in comparison with a placebo control 
group. Campbell et al. (1971), studying cognitive style 
dimensions, reported less impulsive responding and improved 
ability to inhibit incorrect responses in children receiving 
methylphenidate. Conners and his associates (Conners, 1972; 
Conners & Eisenberg, 1963; Conners, Eisenberg, & Sharpe, 
1964), in several articles have reported less impulsive 
responding as measured by the Porteus Maze Test in methyl-
phenidate groups. 
Werry (1970), reviewing the laboratory work on drugs and 
learning, concludes that under certain conditions, either 
34 
simple repetitive motor tasks or tasks which do not neces-
sitate a higher level of cognitive organization, improvement 
is found in areas of vigilance, speed, short-term memory, 
and motor control. Cohen, Douglas, and Morgenstern (1971), 
in their review, found methylphenidate to improve attention, 
reduce impulsivity, increase ability to plan and correct 
errors, and shorten reaction times. 
Summarizing cognitive data, Weiss et al. (1971) conclude 
that methylphenidate does appear to have a somewhat unpre-
dictable but positive effect on a variety of tests. They 
caution, however, that final conclusions are still 
unwarranted as to the specific cognitive functions altered. 
Antidepressant Drug Treatment 
As indicated previously, stimulant drugs are the most 
generally prescribed and are considered to be the most 
effective in the treatment of the MBD child. The search for 
alternative pharmacological agents continues, however, for 
there are certain reservations regarding the stimulants, 
Huessy and Gendron (1970) indicate that in many children who 
have improved with treatment, there is an abrupt change 
between 11 - 13 years, with continued treatment resulting in 
an excitatory response to the drugs as found in adults. 
Wender (1971) reported two episodes in which MBD adolescents 
attempted to become "high" on amphetamines. Their comments 
were of a pleasant, perhaps calming effect, although 
apparently not euphoric. Following both episodes, treatment 
with imipramine, classified as a tricyclic antidepressant 
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drug, was instituted, with the result being a response 
similar to that produced by the stimulants in younger sub-
jects, namely decreased motor activity and impulsivity, and 
improved social compliance and academic performance. The 
author cautioned, however, that in two or three other cases, 
imipramine was found to be ineffective. 
Stating that the side effects of the stimulants indicated 
the need for a more satisfactory treatment, Rapoport (1965) 
instituted imipramine therapy for a variety of behavior dis-
orders similar to those previously treated with stimulants. 
Past studies of imipramine in the treatment of enuresis had 
reported as an incidental effect positive behavioral change. 
Rapoport found, based on reports from parents, schools, and 
psychological testing, an 80% improvement rate with 
imipramine. Behaviorally, the drug was reported to increase 
alertness, decrease temper and compulsive behavior, and to 
improve sleep. Cognitively, improvements in intellectual 
and academic measures were obtained. 
Krakowski (1965),, in a placebo controlled study, reported 
a ?2io improvement rate with amitriptyline, another of the 
tricyclic antidepressant drugs. Overall ratings of improve-
ment were based on psychological testing and reports of 
scholastic performance and improvement in target symptoms 
such as activity, anxiety, and aggression. 
Using criteria of parents' and teachers' reports, and 
academic performance as measured by report cards, Huessy and 
Wright (1970) found a 67% improvement rate in an MBD sample 
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receiving imipramine. When the treatment was temporarily 
interrupted after 4 months, only 4% of the subjects 
continued to do well. Based on their results, and the ad-
vantages of a single daily dose and minimal side effects, 
the authors conclude that imipramine is the drug of first 
choice in the treatment of MBD children. 
Drug Treatment Critique 
In the above review, evidence has been presented of the 
behavioral and, although less predictable, cognitive 
improvements resulting from short-term trials of medication. 
There have been, however, concerns and issues raised in 
regard to the methodology of the research, and also in 
regard to the long-term effects of drug treatment. 
In a review of over 90 articles on the use of stimulants, 
McMahon, Deem, and Greenberg (1970) reported that only five 
met basic research design standards, including pre- and 
posttests, double-blind, and placebo procedures. 
Sulzbacher (1971), surveying the literature on behavior 
modifying drugs and children, found that of the more than 
1100 studies reviewed, only 210 were considered to be con-
trolled. In these 210, it was further found, that the more 
subjective (clinical opinion and rating scales) the measure-
ment, the greater the report of significant differences 
between drug and placebo groups; given the criteria of 
psychological tests and direct behavioral measurement, rela-
tively few studies reported such differences. 
Apart from the methodological issues of drug research, 
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there are questions concerning the judiciousness of pharma-
cological treatment for MBD children. Side effects of 
stimulant and antidepressant drugs are generally reported 
to be minimal and manageable. There are, however, reported 
instances, although rare, of severe physical and behavioral 
reactions accompanying treatment. Lucas and Weiss (1971) 
presented two cases. of hallucinosis and other gross 
behavior changes such as catatonic withdrawal and bizarre 
mannerisms in children receiving methylphenidate. Brown, 
Winsberg, Bialer, and Press (1973) observed the development 
of seizures concomitant with imipramine therapy in three 
children without previous history of convulsive disorders. 
Even if toxicity is rarely a problem in short-term 
research, treatment may continue for months or years, and 
little is known of the long-term effects of drugs on 
development in children. Safer, Allen, and Barr (1972) 
reported that in nine children receiving dexedrine or 
methylphenidate for 2 or more years, weight gains were sup-
pressed, and although more variable, there was an indication 
that percentile height was decreased in some subjects. The 
authors indicated that further research is needed, but 
nevertheless termed the findings alarming. 
In children approaching or beyond puberty, there are 
added concerns, especially with the stimulant drugs as 
indicated above, of potential abuse or addiction. The only 
research available has not shown evidence of habituation or 
abuse in later years. In a follow-up questionnaire survey 
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of 100 children previously treated with stimulants, Laufer 
(1971) found that of approximately 6o% of the subjects 
responding: 97% reported never having overdosed with any 
form of medication; 95% reported never having experimented 
with stimulants; and 91% reported never having experimented 
with marijuana or LSD. While there may be no evidence of 
drug risk in later years, it is nevertheless recommended 
that the risk of potential experimentation in adolescence 
be recognized (Department of Health, Education, and Welfare, 
1971; Lucas & Weiss, 1971). 
Behavioral Treatment 
Marwit and Stenner (1972) comment that crucial to the 
understanding and treatment of the MBD child is the realiza-
tion that his heightened activity level is not a learned 
response, and for that reason cannot be unlearned; since 
there is a need for the child to express this activity, it 
makes little sense to attempt to eliminate or extinguish it 
other than by pharmacological means. Nevertheless, 
modification of hyperactivity has been attempted by 
behavioral rather than pharmacological means, with the 
evidence indicating that irrespective of etiology, behavior 
modification techniques can be effective. 
Not surprising, behaviorists have not written specifi-
cally of "minimal brain dysfunction." They have, however, 
recognized that hyperacitivity is a complex dimension, 
operationally defined by a number of behavioral subclasses 
such as not attending, moving about, and making noise 
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(Patterson, Shaw, & Ebner, 1969). Whatever the antecedents 
of these high rate behaviors, constitutional, emotional, or 
environmental, they are considered detrimental to the 
development of social and academic skills (Doubros & 
Daniels, 1966; Patterson, Jones, Whittier, & Wright, 1965). 
Operant Techniques 
Within the behavior modification literature, one of the 
earliest studies with a hyperactive child was presented by 
Patterson~ al. (1965). Subsequent to the establishment 
of a baseline of nonattending behavior, training was 
instituted within the classroom, with the subject receiving 
signals contingent upon attending behavior. The signals 
earned reinforcers for the subject and his class following 
each conditioning session. In comparison with a control 
subject, the experimental subject showed significantly fewer 
nonattending behaviors during the training phase, and this 
difference was maintained during a 4-week extinction phase. 
The authors did find that during the conditioning of 
attending behavior, various components of nonattending 
behavior were differentially affected. Thus, gross motor 
movements were only temporarily decreased by the procedure, 
but fiddling and distractibility showed marked decrements 
throughout. 
Reviewing six studies using essentially the same proce-
dure, Patterson et al. (1969) found that results similar to 
the above were replicated by investigators in different 
settings, working with hyperactive children of different 
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ages and IQs, and with varying levels of organic impairment. 
Decreases in deviant behavior ranged from about 10 to J6% 
(median 20%), and were obtained at an estimated cost of from 
J to 10 hours of intervention time. 
Relating to the treatment of the hyperactive child, apart 
from the studies reviewed by Patterson et al. (1969), are 
numerous other classroom and laboratory reports of the suc-
cessful application of operant conditioning procedures. 
Edelson and Sprague (1969) found that activity level as 
measured by seat cushion could be either raised or lowered 
with the application of contingent reinforcement. They 
indicated, however, that by just controlling movement, one 
does not necessarily control attention. Other studies have 
targeted attention specifically, reinforcing visual orienta-
tion (Quay, Sprague, Werry, and McQueen, 1967) or on task 
behavior (Allen, Henke, Harris, Baer, & Reynolds, 1967; 
Broden, Bruce, Mitchell, Carter, & Hall, 1970; Coleman, 
1970; Doubros & Daniels, 1966; Nixon, 1969). 
Academic achievement has likewise been specifically tar-
geted, with contingent reinforcement resulting in improved 
performance (Glavin, Quay, Annesley, & Werry, 1971; 
McKenzie, Clark, Wolf, Kothera, & Benson, 1968; Sluyter & 
Hawkins, 1972; Wadsworth, 1971). 
While the above studies have been successful in modify-
ing activity, attention, and achievement, less successful 
and consistent are the persistence and generalization of 
these behavioral changes, As did Patterson et al. (1965) 
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in their earlier investigation, resistance to extinctions 
has been obtained by some experimenters (Doubros & Daniels, 
1966; Knowles, Prutsman, & Raduege, 1968; Nixon, 1969). 
However, other studies have found that with the cessation 
of behavioral procedures, improvements are not maintained 
(Edelson & Sprague, 1969; Quay et al., 1967; Sluyter & 
Hawkins, 1972), Also, in studies which have attempted to 
transfer control initially gained by primary reinforcement 
to control by teachers' social reinforcement, a decline in 
improvement has likewise been found (Coleman, 1970; Quay 
et al., 1967). It should be emphasized, however, that such 
findings are not specific to the treatment of the hyper-
active child, for as a review by O'Leary and Drabman (1971) 
has indicated, generalization across situations and 
generalization across time are critical issues in all class-
room reinforcement procedures; generalization must be 
programmed rather than expected. But as Patterson (1971) 
comments, the question of how the school system can provide 
the reinforcers necessary for the success and maintenance of 
behavioral programs is an area just beginning to receive 
attention. 
Patterson (1971) writes that in contrast to classroom 
intervention, the technology of family intervention is in a 
primitive state. Relevant to the treatment of the hyper-
active child, there are reports of the successful 
modification of disruptive, aggressive, and oppositional 
behaviors, with parents in the role of behavior modifier 
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(Hawkins, Peterson, Schweid, & Bijou, 1966; O'Leary, 
O'Leary, & Becker, 1967; Patterson & Brodsky, 1966; Wahler, 
1969a, 1969b; Wahler, Winkel, Peterson, & Morrison, 1965; 
Zeilberger, Sampen, & Sloane, 1968). 
As did the classroom studies reviewed, most of the 
studies with parents have relied on direct intervention by 
the experimenter in initial phases of training. In the 
work with parents, this experimenter intervention has often 
been in the form of modeling or cueing, in home or clinic, 
the specific behavioral procedures to be used. 
In teaching parents to observe behavior and to plan 
behavioral programs, Patterson and Gullion (197la) have 
found that between 5 - 15 weekly training sessions are 
typically needed before adequate control of the child's 
behavior is obtained. In approximately 1/3 of their 
families having severe "problem children," the didactic 
presentation (observational training, reading, and discus-
sion) of behavior principles was not sufficient, and the 
more direct procedures of cueing and modeling were required. 
In the extreme, when it was necessary for the experimenter 
actually to enter the home, the cost of such effort in 
terms of professional time ranged from 9 to 46 hours. 
Patterson (1971) concludes that training programs for 
parents appear a promising procedure, but as yet details 
necessary to evaluate the relative effectiveness are lacking. 
Self-Management Techniques 
In the above studies, reinforcement contingencies have 
43 
been arranged and implemented by the therapist or parent. 
Self-control, in contrast, is a procedure in which the 
individual initiates responses to control the probability 
of his own behavior (Cautela, 1969). Relevant to the 
behavioral treatment of the hyperactive child, a body of 
literature is available focusing upon the technique of 
verbally mediated self-control. 
Presenting the theoretical basis for self-control train-
ing, Meichenbaum and Goodman (1969, 1971) explain that the 
internalization of verbal commands is considered a critical 
step in a child's development of voluntary control. 
Developmentally, verbal control begins with the speech of 
others having a directive function and progresses to the 
point at which the child's own internalized speech becomes 
self-directive, his own words gaining the status of 
discriminative stimuli. 
Palkes, Stewart, and Kahana (1968) and Pontius (1972) 
hypothesize that for the hyperactive child, this develop-
mental progression is not maintained, and his verbalizations 
do not optimally serve to control or channel his activity 
and impulsivity. Comparing impulsive and reflective 
children, Meichenbaum and Goodman (1969) did find that 
impulsive children rely less on the semantic content of 
their own speech, and under covert self-instructions, 
evidence less verbal control than do reflective children. 
In an attempt to modify the impulsivity of hyperactive 
subjects, Palkes et ~· (1968) instituted training in 
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self-directed verbal commands. During two training ses-
sions, the children worked on a series of tasks, verbalizing 
aloud a set of commands prior to responding to any subpart 
of a task. The commands were printed on cards, and 
instructed the child to "stop," "listen," and "look and 
think" before answering. Directly following training, in 
comparison with a control group given the same tasks but 
without the command training, the experimental group was 
significantly less impulsive as measured by the quantitative 
and qualitative scores of the Porteus Maze Test. 
Using a single training session, Meichenbaum and Goodman 
(1971) compared modeling alone with modeling plus self-
instructional training. Following treatment, it was found 
that while both groups had slower decision times, modeling 
plus self-instructional training was more effective in 
altering decision times and in reducing errors. A similar 
procedure, over four sessions, resulted in similar cognitive 
improvements, with the gains following self-instructional 
training maintained on 4 week follow-up. 
Although finding that their subjects had made cognitive 
gains, Meichenbaum and Goodman (1971) reported that based on 
classroom observation and teachers' ratings, no behavioral 
improvement followed training. Pollack (1968) did specifi-
cally focus upon training behavioral self-control. Verbal 
control training was instituted in an attempt to modify 
frustration reactions. Subjects were first taught to label 
their behavior, and were then given verbal and motor cues to 
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perform at the onset of explosive behavior in an attempt to 
inhibit the reaction. Results analyzed qualitatively 
indicated that significant behavioral improvement was seen 
in four of five cases, although the gains varied greatly in 
degree, with this variability appearing to be directly 
related to individual differences in language and conceptual 
skills. 
Techniques with Normal versus Hyperactive Children 
As the above review has indicated, the behaviors of 
hyperactive children have been modified by behavioral tech-
niques, and there is no reason to assume that the laws of 
learning are in any way different for this particular popu-
lation. The question remains, however, whether or not the 
modification of hyperactivity and its associated behaviors 
is in some way more difficult than the modification of other 
behavioral dimensions. 
Operationally defined, it is the high rate of his 
behavior which is one of the distinguishing characteristics 
of the hyperactive child (Patterson et al., 1969). In 
working with high rates of deviant behavior, Patterson 
(1971) suggests that longer periods of training may be 
required to obtain long-term control. But not only does the 
hyperactive child present one high rate behavior, upon 
observation a number of clusters of such behavior may be 
present. Given this array, Benson (1969) and Patterson 
(1971) suggest that it may initially be necessary for the 
experimenter to work directly with the child, bringing the 
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behavior under his control, and then transferring this con-
trol to parent, teacher, and/or peers. 
In addition to the difficulties specifically related to 
the control of multiple high rate behaviors, it has also 
been suggested that the overall susceptibility of the hyper-
active child to behavior modification techniques is somewhat 
diminished. 
Comparing hyperactive and control subjects on a tone 
discrimination task, Boydstun et al. (1968) reported that 
l/3 of the hyperactive children showed procedural irregular-
ities, such as interfering with the equipment, which 
interrupted the session. On the task itself, while 92% of 
the control group did reach criterion, only 62% of the 
hyperactive group attained a comparable level of performance. 
Dykman et al. (1970), comparing hyperactive and norma-
active groups, both of average intelligence, found that the 
hyperactive children required extra instructions to learn a 
light discrimination task, and were slower in responding 
and higher in error rate during the acquisition and 
differentiation phases of the study. 
Freibergs and Douglas (1969) reported that on a concept 
attainment task, hyperactive children did more poorly than 
controls under partial reinforcement, but found no 
difference between groups with continuous reinforcement. 
Comparing the EEG recordings of hyperactive and normal 
control subjects during evoked potential procedures, 
Milstein, Stevens, and Sachdev (1969) found the hyperactive 
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group to have exaggerated initial responses to novel stimuli 
and a decreased capacity to disattend to redundant stimuli. 
All of the above authors have hypothesized that neurolog-
ically, defects in cortical arousal and inhibitory 
processes impede sustained attention, and that in turn, the 
defects in sustained attention impede the susceptibility of 
the hyperactive child to modification by behavioral proce-
dures. 
Pharmacological versus Behavioral Treatment 
Commenting upon the relationship between pharmacologists 
and behaviorists, Sprague and Werry (1971) write of a bar-
rier of communication, a state in which neither group seems 
aware of the other. In fairness, however, it must be noted 
that in the drug treatment literature, frequent reference 
is made of other modes of treatment. Eisenberg (1972) 
stresses that drugs do not produce learning, but make it 
possible; remedial education and counseling are essential 
if the child is to resume a normal developmental course. 
Such statements are by no means unusual, with several other 
authors having indicated the need for concomitant psycholog-
ical and educational management. What is not found, 
however, is a presentation by these same authors of what 
specifically constitutes these adjunct therapies. 
Pharmacological management is generally the sole treatment 
detailed; then, at best, cursory mention is added of the 
need for prompt reward or discipline, consistency and firm-
ness, in home and school management. Given this state of 
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benign neglect, it is perhaps not surprising that direct 
comparisons of pharmacological and behavioral therapies, or 
for that matter direct comparisons of any therapies, in the 
treatment of the MBD child are limited. 
In the early 1960s, Eisenberg, Gilbert, Cytryn, and 
Melling (1961) compared three short-term treatments: 
therapy, therapy plus placebo, and therapy plus perphenazine 
(a phenothiazine derivative), Therapy was described as sup-
portive, consisting of five sessions with parents and five 
with child over 3 months, No further details were provided. 
Based on a pooling of reports from parents, teachers, and 
psychiatrists, no difference was found between the therapy 
and therapy plus placebo conditions; only 2 of the 12 com-
bined MBD subjects were significantly improved. In the 
therapy plus perphenazine group, 6 of 11 children were sig-
nificantly improved. Based on a clinic report, apart from 
the study, of a therapy alone condition, it was reported 
that the drop out rate for MBD families was 6o% by the third 
month. The authors concluded that the model of treatment 
for neurosis, short-term psychotherapy, is unsuitable in the 
approach to the treatment of minimal brain dysfunction. 
Recently, Conrad et al. (1971) presented a comparison of 
amphetamine therapy and prescriptive perceptual-cognitive 
tutoring over the course of 4-6 months. Their design 
entailed four groups: placebo/no tutoring; placebo/tutoring; 
amphetamine/no tutoring; and amphetamine/tutoring. Results 
indicated that behaviorally, parents' and psychologists' 
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ratings reflected a reduction in hyperactivity and improve-
ment in attention only for those children receiving 
medication. However, teachers perceived greater behavioral 
improvement ln the amphetamine/tutoring group than in the 
amphetamine/no tutoring condition. Cognitively, medication 
contributed to improvement on a number of tasks, those 
mostly affected by distractibility and impulsivity. 
Amphetamine/tutoring interactions indicated that reduction 
in activity and improvement in attention enabled subjects to 
make use of their tutoring experience in some perceptual-
motor areas. It was concluded that regardless of the 
remedial approach employed, drug therapy is an important 
adjunct, but medication alone is sufficient treatment only 
for those MBD children having no specific learning problems. 
A direct comparison reported in the literature between 
pharmacological treatment and what may properly be termed 
behavior modification is a laboratory study by Sprague and 
Christensen (1972). Four stages of the study were described: 
a non-drug baseline measurement of activity as recorded by 
seat cushion; a drug baseline measurement with one group 
receiving methylphenidate and another placebo; a behavioral 
procedure during drug or placebo treatment; and a post-
behavioral, extinction procedure. During the third stage, 
the behavioral procedure, all subjects received reinforce-
ment contingent upon reduced seat movement. The results 
indicated that throughout the sessions, the placebo subjects 
were higher in activity than those receiving methylphenidate. 
50 
With the introduction of reinforcement, seat activity was 
significantly reduced in both groups, but as indicated, 
subjects receiving methylphenidate continued to be superior, 
and also had less variability in their performance. During 
the extinction stage, placebo subjects showed an immediate 
increase in movement, while no comparable increase was 
found in the methylphenidate subjects. The authors conclude 
that a combination drug/behavior modification treatment is 
superior to either condition alone. 
Summary 
Of the drugs employed in the treatment of minimal brain 
dysfunction, central nervous stimulants are the most widely 
prescribed, and within the stimulant grouping, based on 
efficacy and toxicity, methylphenidate appears to be of 
choice. Although not always statistically significant, 
methylphenidate has consistently been found superior to 
placebo in producing positive behavioral change. The evi-
dence for cognitive improvement has been less consistent, 
but overall, the drug does appear to have a positive effect 
on the more discrete aspects of cognitive style, such as 
attention and impulsivity; however, final conclusions as to 
the specific cognitive functions altered are still unwar-
ranted. 
The search for alternative pharmacological treatment 
continues, for there are reservations with regard to the 
side effects and addiction or abuse potential of the stimu-
lants. There have been a few studies suggesting the 
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usefulness of treatment with tricyclic antidepressant drugs, 
imipramine and amitriptyline. As with the stimulants, both 
behavioral and cognitive improvement have been reported 
with the antidepressants. However, the effects of stimu-
lant and antidepressant drugs have not, as yet, been 
directly compared. 
Behaviorists have recognized hyperactivity as a complex 
dimension, having serious implications for social and 
academic development. Relevant to the treatment of the 
hyperactive child, operant techniques in the classroom have 
been found effective in the modification of activity, atten-
tion, and achievement, although still troublesome are the 
persistence and generalization of these changes. With 
parents in the role of behavior modifier, the successful 
modification of disruptive, aggressive, and oppositional 
behaviors have been reported. As with classroom studies, 
most work with parents has relied on direct experimenter 
intervention during the initial phases. Self-management 
techniques, following a model of verbally mediated self-
control, have also been found effective, specifically in the 
modification of cognitive impulsivity and behavioral frustra-
tion reactions. 
Regarding the use of behavioral techniques with hyperac-
tive children, there is evidence suggesting that the 
modification of multiple high rate behaviors requires longer 
periods of training along with direct experimenter interven-
tion, and that the susceptibility of the hyperactive child to 
modification may be somewhat diminished as a result of 
neurologically-based defects in sustained attention. 
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Comparisons of pharmacological and behavioral treatments 
are limited. The research that is available suggests that 
in the laboratory treatment of hyperactivity, methylpheni-
date is superior to behavioral procedures, but that a com-
bination drug/behavioral treatment is superior to either 
condition alone. The effects of pharmacological and 
behavioral treatments have not, as yet, been directly com-
pared within the clinic setting. 
CHAPTER 3 
METHOD 
Problem and Hypotheses 
It is the aim of the present study: 1. to compare the 
behavioral and cognitive effects of pharmacological and 
behavioral therapies in the short-term, clinical treatment 
of minimal brain dysfunction; and 2. to compare the 
behavioral and cognitive effects of stimulant (methylpheni-
date) and antidepressant (imipramine) drugs in the 
short-term, clinical treatment of minimal brain dysfunction. 
The specific hypotheses to be tested are: 
Hypothesis 1 
Behavioral treatment does not differ from two types of 
pharmacological treatment (imipramine and methylphenidate) 
in its effects upon: 
a. selected behaviors, as measured by parents' and 
teachers' ratings, of MBD children. 
b. selected areas of cognitive functioning, as mea-
sured by teachers' ratings and psychological 
testing, of MBD children. 
Hypothesis 2 
Imipramine does not differ from methylphenidate in its 
effects upon: 
a. selected behaviors, as measured by parents' and 
teachers' ratings, of MBD children. 
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b, selected areas of cognitive functioning, as mea-
sured by teachers' ratings and psychological 
testing, of MBD children. 
Subjects 
From referrals to the Psychopharmacology Clinic of the 
University Affiliated Program for Child Development, 
Georgetown University Hospital, 29 boys were selected for 
the study. Subjects had been referred by physicians and 
school personnel for behavior and/or learning problems. 
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Based on pediatric and psychiatric evaluations, and a 
review of behavior rating scales completed by parents and 
teachers, the diagnosis of minimal brain dysfunction with 
hyperactivity was made by a child psychiatrist. Primary 
criteria for inclusion in the sample were behaviors of 
chronic and sustained hyperactivity, distractibility, and/or 
impulsivity as reported by the home and school. As specified 
by Clements (1966), the diagnosis of minimal brain dysfunc-
tion is reserved for the child whose neurologic symptoma-
tology is mild or borderline, whose intellectual functioning 
is at least within near average range, and whose behavioral 
and cognitive disabilities are associated with deviations of 
the central nervous system. Thus, excluded from considera-
tion were children with gross neurological dysfunctions, 
those who did not meet the minimum requirement of a Full 
Scale score of 70 on the Wechsler Intelligence Scale for 
Children, and/or those with primary emotional disorders. 
The subjects selected ranged in age from 6 through 12 
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years (mean= 9.0), with WISC scores ranging from 72 through 
126 (mean= 99.6). Approximately half of the subjects were 
reported by the school as having received some form of 
remedial instruction (ungraded or special class, remedial 
reading, speech correction, or tutoring). Some subjects had 
previously received psychological or pharmacological therapy, 
but not within the 6 months prior to their acceptance into 
the study. Although no social class criterion was specified, 
the families judged able to meet the clinic regimen, which 
included visits to the hospital, telephone progress contacts, 
and a private or community referral source for pharmacologi-
cal management following the study, were predominantly of 
middle socioeconomic status. 
Procedure 
At admission to the clinic, subjects were assigned in 
random permutations of three to the treatment groups: 
imipramine (N = 10); methylphenidate (N = 10); or behavior 
modification (N = 9). The total time of treatment for each 
child was 6 weeks. 
Pharmacological Treatment 
For subjects within the imipramine and methylphenidate 
groups, medication was managed by a psychiatrist. Parents 
were encouraged to maintain telephone contact during the 
6-week period, and a definite appointment with the parents 
was scheduled at J weeks to assess treatment progress. 
Based on the parental reports of behavior at home and at 
school, and any side effects occurring during the course of 
treatment, dosage was individually titrated ranging from 
75- 150 mg/daily of imipramine, and 10- JO mg/daily of 
methylphenidate. 
Behavioral Treatment 
Meetings with parents. Parents of subjects assigned to 
the behavior modification group were individually seen by 
the author at the clinic 1 hour per week during the 6-week 
treatment period. 
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During the first session, parents were asked to discuss 
the general reason for their referral to the clinic. The 
behavioral approach was then presented, emphasizing that 
irrespective of etiology, the goal is to change behavior by 
changing reinforcement contingencies. Parents, with the 
aid of the experimenter, targeted specific problem behaviors 
to be considered during the treatment period (Table 1). 
They were asked to observe one of the behaviors during the 
coming week, and were supplied a copy of the programmed text 
Living with Children (Patterson & Gullion, 197lb) to be com-
pleted by the next meeting. 
At the second session, building upon the information 
obtained from Living with Children, specific behavioral 
principles of social and token reinforcement, extinction, 
contingency contracting, shaping, and modeling were elabo-
rated in regard to the specific problem behavior under 
observation by the parents. Working together, parents and 
experimenter devised a behavioral program to be instituted 
during the coming week. 












Behavior Modification Group 
Target Behaviors 
Target Behaviors 
Interaction with teacher 
Completion of classroom assignments 
Getting ready for school on time 
Fighting with sibling 
Fighting with sibling and peers 
Completion of classroom assignments 
Hyperactivity in classroom 
Coming home on time 
Interaction with father 
Completion of homework assignments 
Completion of homework assignments 
Fighting with siblings 
Fighting with sibling 
Coming home on time 
Completion of chores 
Fighting with peers 
Obeying parents 
Completion of classroom assignments 
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the program as reported by parents, refinements or exten-
sions, when appropriate, were implemented. 
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Meetings with subjects. While their parents were 
meeting with the author, subjects assigned to the behavior 
modification group were also individually seen. These ses-
sions, conducted by a graduate student from the Department 
of Counseling and Personnel Services, University of 
Maryland, had a dual emphasis, behavioral control and cog-
nitive control. 
During the first part of a session, working from the 
problem area targeted by their parents, subjects were asked 
to discuss specific encounters, describing their behavior 
and the consequences of the behavior. Following the method 
of behavior rehearsal (Wolpe & Lazarus, 1966), the experi-
menter and the given subject then reenacted these incidents, 
rehearsing alternative, adaptive behaviors suggested by 
subject or experimenter, and, when necessary, modeled by 
the experimenter. 
The second part of a session, devoted to cognitive con-
trol, followed the method of verbally mediated self-control. 
Training tasks were assembled in the areas of trail 
making, matching pictures, and embedded figures, these areas 
chosen based on the study by Palkes et al. (1968). The 
specific training items for each session are contained in 
Appendix A. 
Also derived from the study by Palkes et al. (1968), 
three visual reminder cards were constructed, each 5 x? 
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inches, with commands printed in red and drawings in black. 
Card 1 read "Look and think before I move"; Card 2 "Look 
and check all the pictures before I answer"; and Card 3 
"Look and think before I answer" (Appendix B). 
Prior to the execution of training tasks, subjects were 
told: 
One of the things we are going to do is play 
some games. The important thing is to try 
not to make a mistake. I want you to get 
them right every time on your first try. 
One way to get them right is to think about 
your answer. These cards will help you to 
think about your answer. 
During training, subjects verbalized commands printed on 
the visual reminder cards prior to responding to any subpart 
of a task. Responses correct upon initial attempt were 
reinforced. Session models were as follows: 







FR 3 reinforcement 
Covert commands 
FR 3 reinforcement 
Covert commands 
Final reinforcement 
A more detailed description of command and reinforcement 
procedures is provided in Appendix C. 
Between clinic sessions, subjects were given practice 
assignments to complete daily. These assignments, with the 
appropriate commands attached, duplicated the areas covered 
by training tasks, trail making, matching pictures, and 
embedded figures. Appendix D contains the specific practice 
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items by day and week. 
Dependent Measures 
For all groups, prior to and following treatment, behav-
ioral and cognitive measures were obtained. 
Behavioral Measures 
For hypotheses la and 2a, behavioral effects of treatment 
were assessed by the following: 
Parent variables. Parents completed the Parent's Ques-
tionnaire (Conners, 1970), a behavior rating scale which is 
scored for eight factors: Conduct Disturbance, Anxiety, 
Hyperactivity, Learning Problem, Somatic Complaints, Obses-
sional Traits, Antisocial Behavior, and Muscular Tension. 
The specific observations comprising each of these factors 
are contained in Appendix E. Each item is rated for the 
degree to which it describes the child: not at all, just a 
little, pretty much, or very much. In scoring, these item 
ratings are assigned weights of 0- J, respectively, and then 
the appropriate items are summed to obtain factor-based 
scores. Reliability and validity data for the Parent's 
Questionnaire are summarized in Appendix F. 
Teacher variables. Teachers were asked to complete pre-
and posttreatment the Preliminary School Report and the 
Follow-Up School Report, respectively (Conners, 1969), 
scales yielding four factors: Conduct Disturbance, Dis-
tractibility, Anxiety, and Hyperactivity. The behavioral 
observations comprising the factors of the School Report are 
contained in Appendix G. The scoring procedures are 
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identical to those for the Parent's Questionnaire. 
The Follow-Up School Report, in addition, provides for 
global ratings of behavioral improvement in: Classroom 
Behavior, Overall Behavior, Group Participation, and Atti-
tude toward Authority. Categories of much worse, a little 
worse, unchanged, improved, and much improved are provided 
to describe behavioral change. In scoring, weights of 
1-5, respectively, are assigned to obtain the global 
ratings of improvement. Reliability and validity data for 
the School Report are summarized in Appendix H. 
Cognitive Measures 
For hypotheses lb and 2b, cognitive effects of treatment 
were assessed by the following: 
Teacher variables. On the Follow-Up School Report, mea-
sures of academic achievement were obtained from teachers' 
global ratings of Reading, Spelling, and Arithmetic. The 
scoring procedures for these ratings of academic improvement 
are identical to those for the global ratings of behavioral 
improvement as described above. 
Sub.ject variables. Subjects were administered a battery 
of six psychological tests pre- and posttreatment: the 
Wechsler Intelligence Scale for Children, consisting of the 
10 standard Verbal and Performance subtests and the supple-
mentary Digit Span subtest (Wechsler, 1949); the Reading, 
Spelling, and Arithmetic subtests of the Wide Range Achieve-
ment Test (Jastak, Bijou, & Jastak, 1965); the Porteus Maze 
Test (Porteus, 1965); the Bender Gestalt Test for Young 
L 
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Children (Koppitz, 1964); the Developmental Test of Visual-
Motor Integration (Beery & Buktenica, 1967); and the 
Draw-A-Person (Goodenough & Harris, 1963), 
All psychological tests were administered and scored by 
the author, following the standard procedures described in 
the respective test manuals. As the Wechsler scale was a 
selection criterion, it was always administered first in the 
battery. Other tests were ordered based on random permuta-
tions to control for possible sequence effects. 
Scoring was blind with respect to subjects' group assign-
ments for all tests administered pretreatment, and for the 
Porteus Maze, VMI, and Draw-A-Person tests administered 
posttreatment. Given the nature of the tests and/or the 
demands for school reporting, it was necessary to score pro-
tocols from the Wechsler, Wide Range, and Bender Gestalt 
either during testing or immediately following a subject's 
completion of the treatment; thus, in the posttreatment 
scoring of these three tests, the treatment anonymity of 
behavioral and pharmacological subjects could not be main-
tained, although the specific drug assignment of 
pharmacological subjects was still unknown. Independent, 
blind scoring was obtained for the Bender Gestalt Test, with 
the interrater reliability being ,96. 
Statistical Analysis 
Analyses of covariance, with pretreatment scores as the 
covariates and posttreatment scores as the criteria were 
computed on the data from the behavior factor ratings and 
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the psychological test battery. 
Global ratings of improvement were treated by analysis of 
variance procedures. 
In the application of analysis of variance and analysis 
of covariance procedures, the assumption of homogeneity of 
variance was tested by Hartley's F Test. max 
For analysis of covariance procedures, the additional 
assumption of homogeneity of regression was conducted by 
computer program. When the assumption of homogeneity was 
not met, the Neyman-Johnson technique (Johnson & Jackson, 
1959) was then applied to all three pairs of groups. This 
technique is used to locate a region of significant mean 
differences along a covariate for two groups measured on a 
criterion, when regressions are heterogeneous. 
To test hypotheses 1 and 2 specifically, preplanned 
orthogonal contrasts were constructed comparing the average 
of the pharmacological treatment effects with the behavioral 
treatment effects, and comparing imipramine treatment 
effects with methylphenidate treatment effects, respective-
ly. In the determination of differential treatment effects, 
a significance level of .05 was set. However, since this 
study was considered exploratory, for purposes of further 
research suggestions, group differences at the .10 level of 
significance were also reported. 
When the F ratio from an analysis of variance or analysis 
of covariance was significant at the critical value for 
o( = .05, the Newman-Keuls technique for postmortem contrasts 
was applied to assess the pairwise contrasts of imipramine 
treatment versus behavior modification, and methylphenidate 
treatment versus behavior modification. 
Group means and error terms for the orthogonal contrasts 
and Newman-Keuls technique were adjusted appropriately when 
analysis of covariance procedures were in effect (Dayton, 
1970). 
Product-moment correlations were computed amongst the 
change scores from the behavior factor ratings, the change 
scores from the psychological test battery, and the global 
ratings of improvement. 
Data were analyzed at the Computer Science Center of the 
University of Maryland. The MANOVA program (Clyde, Cramer, 
& Sherin, 1966) was utilized in analysis of variance, 
analysis of covariance, and orthogonal contrast procedures; 
the ANCOVA2 program (Dayton, undated) was additionally 
applied in covariance analyses for the testing of the homo-
geneity of regression assumption, and the application of 
Neyrnan-Johnson tests when indicated; and the FACTOR program 





To compare the average of the imipramine and methylpheni-
date treatments with the behavior modification treatment, 
the following preplanned contrast model (ignoring weights 
for unequal sample sizes) was constructed: 
Behavioral Measures 
Hypothesis la: 
Behavioral treatment does not differ from two types of 
pharmacological treatment (imipramine and methylpheni-
date) in its effects upon selected behaviors of MBD 
children. 
Parent variables. For the data of the Parent's Question-
naire, the assumption of homogeneity of variance was met on 
all but the Obsessional Traits factor. To equalize sample 
variances on this factor, square root transformations were 
performed on the scores, and the analysis was then continued. 
The assumption of homogeneity of regression was met on 
all but the Anxiety and Antisocial Behavior factors. In 
* Because of the unequal sample sizes of the groups, in 
the actual statistical computations, the sample sizes were 
entered into the contrast model as weights. The actual con-
trast, with weights and coeffici~ts, wa~ thus: 
90(YI + YM) - l80YB 
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Figure 1, the within-group regression lines, shown only over 
the observed range of pretreatment scores, are plotted for 
the Anxiety factor. As designated by the Neyman-Johnson 
technique, for imipramine and behavior modification groups, 
regressions were heterogeneous within the region of pre-
treatment scores between 0 and l.J9. The regression lines 
for methylphenidate and behavior modification did not differ 
significantly anywhere along the pretreatment axis, and 
therefore are not plotted together. 
In Figure 2, the within-group regression lines for the 
Antisocial Behavior factor are shown. For imipramine and 
behavior modification groups, the region of significant 
heterogeneity was above the pretreatment score of .6?. For 
methylphenidate and behavior modification groups, the 
regression lines above the pretreatment score of .J? dif-
fered significantly. 
By orthogonal contrast procedures, no difference at or 
beyond the .10 level of significance was obtained between 
the average of the pharmacological treatments and the beha-
vioral treatment on any of the factors from the Parent's 
Questionnaire (Appendix I). 
Teacher variables. For the data of the School Report, 
homogeneity of variance and homogeneity of regression 
assumptions were met in all analyses. 
By orthogonal contrast procedures, between the pharmaco-
logical and behavioral treatments, there was no difference 
at or beyond the .10 level based on teachers' factor ratings 
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on the School Report (Appendix J), 
There were differential treatment effects based on 
teachers' global ratings of behavior. Pharmacological treat-
ment, on the average, was superior to behavioral treatment 
based on teachers' ratings of change in: Group Participa-
tion (p.(. 001), Classroom Behavior (p<· 01), Attitude toward 
Authority (p<· 01), and Overall Behavior (p<· 05, Appendix 
K)' 
To test the specific pairwise contrasts of imipramine 
versus behavior modification, and methylphenidate versus 
behavior modification, Newman-Keuls tests were then applied 
to the global rating data. At the .05 level, the only con-
trast between imipramine and behavior modification to reach 
significance was in the category of Group Participation. 
Contrasting methylphenidate with behavior modification, dif-
ferences between group means did exceed the critical value 
at the .05 level in all four categories of behavioral 
change (Appendix L). 
Cognitive Measures 
Hypothesis lb: 
Behavioral treatment does not differ from two types 
of pharmacological treatment (imipramine and methyl-
phenidate) in its effect upon selected areas of 
cognitive functioning of MBD children. 
Teacher variables. For the data of teachers' global 
ratings of academic achievement, homogeneity of variance and 
homogeneity of regression assumptions were met in all analy-
ses. 
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By orthogonal contrast procedures, based on teachers' 
global ratings, pharmacological treatment, on the average, 
was superior to behavioral treatment in the area of 
Spelling (p<:.05). In the area of Arithmetic, the differ-
ence between treatments, in favor of the pharmacological, 
was significant at the .10 level. No differential treat-
ment effects were indicated in Reading achievement 
(Appendix M). 
Specific pairwise contrasts between imipramine and 
behavior modification indicated that there was no signifi-
cant difference at the .05 level between groups in either 
Spelling or Arithmetic achievement. Comparing methylpheni-
date and behavior modification, the difference between 
group means did exceed the critical value at the .05 level 
in the area of Spelling, but not in the area of Arithmetic 
(Appendix N). 
Subject variables, For the data of the psychological 
test battery, the homogeneity of variance assumption was 
satisfied in all analyses. 
The homogeneity of regression assumption was met on all 
but the Vocabulary subtest of the WISC. In Figure J, the 
within-group regression lines for the Vocabulary subtest 
are plotted. For imipramine and behavior modification 
groups, regressions were heterogeneous within the region of 
observed pretreatment scores between 5.00 and 9.90. The 
regression lines for methylphenidate and behavior modifica-
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Fig. J. Within-group regression lines for the Vocabulary subtest of the Wechsler 




By orthogonal contrast procedures, comparing pharmaco-
logical and behavioral treatments on the psychological test 
battery, two variables were significant: behavioral treat-
ment was superior to the average of the pharmacological 
treatments on the Object Assembly subtest of the WISC 
(p<.0.5); and pharmacological treatment, on the average, 
was superior to behavioral treatment on the Qualitative 
Score of the Porteus Maze Test ( p <· 0.5, Appendix 0) . 
The specific Newman-Keuls pairwise contrasts of imipra-
mine versus behavior modification, and methylphenidate 
versus behavior modification, did not reach the .05 level 
of significance ln either analysis. 
Hypothesis 2 
The preplanned contrast model for the comparison of 
imipramine and methylphenidate treatments was: 




Imipramine does not differ from methylphenidate in 
its effects upon selected behaviors of MBD children. 
Parent variables. As indicated above, in order to satis-
fy the assumption of homogeneity of variance, square root 
transformations were performed on the scores from the Obses-
sional Traits factor of the Parent's Questionnaire. 
-l~ Sample sizes for imipramine and methylphenidate groups 
were equal, and therefore did not enter into the model as 
weights. 
As also indicated above, the homogeneity of regression 
assumption was not met on the Anxiety and Antisocial 
73 
Behavior factors. In Figure l, as designated by the Neyman-
Johnson technique, for imipramine and methylphenidate groups, 
regressions were heterogeneous on the Anxiety factor above 
the pretreatment score of 9.27. 
In Figure 2, for imipramine and methylphenidate groups, 
regressions were heterogeneous on the Antisocial Behavior 
factor within the region of observed pretreatment scores 
between 1.25 and 3.85. 
By orthogonal contrast procedures, no difference at or 
beyond the .10 level of significance was obtained between 
imipramine and methylphenidate on any of the factors of the 
Parent's Questionnaire (Appendix I). 
Teacher variables. For the data of the School Report, 
homogeneity of variance and homogeneity of regression 
assumptions were met in all analyses. 
By orthogonal contrast procedures, from the teachers' 
factor ratings of behavior, the difference between imipra-
mine and methylphenidate in the reduction of Hyperactivity 
did reach the .10 level of significance, with methylpheni-
date favored. The differences between groups on the other 
three factors, Conduct Disturbance, Distractibility, and 
Anxiety, were nonsignificant (Appendix J). 
Based on teachers' global ratings of behavior, methyl-
phenidate exceeded imipramine in the categories of Group 
Participation and Attitude toward Authority, both 
differences significant at the .10 level. The groups did 
not differ significantly in the remaining categories of 
Classroom and Overall Behavior (Appendix K). 
Cognitive Measures 
Hypothesis 2b: 
Imipramine does not differ from methylphenidate in 
its effects upon selected areas of cognitive func-
tioning of MBD children. 
Teacher variables. For the data of teachers' global 
ratings of academic achievement, homogeneity of variance 
and homogeneity of regression assumptions were met in all 
analyses. 
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By orthogonal contrast procedures, based on teachers' 
global ratings, methylphenidate resulted in greater 
improvement, at the .10 level of significance, in the areas 
of Spelling and Arithmetic than did imipramine. No differ-
ence between the groups in Reading achievement was found 
(Appendix M). 
Subject variables. For the psychological test data, the 
homogeneity of variance assumption was satisfied in all 
analyses. 
The homogeneity of regression assumption was met on all 
but the Vocabulary subtest of the WISC. As indicated in 
Figure J, for imipramine and methylphenidate groups, 
regressions were heterogeneous on the Vocabulary subtest 
with the region of observed pretreatment scores between 6.00 
and 8.75. 
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By orthogonal contrast procedures, amongst the psycho-
logical test measures, the only difference between groups 
was evidenced on the Draw-A-Person, with the group mean 
of imipramine greater than the mean of methylphenidate at 
the .10 level (Appendix 0). 
For all behavioral and cognitive measures, group means 
and standard deviations are contained in Appendices P. Q. 
and R. 
Related Findings 
In Table 2, the percent of subjects improved based on 
teachers' global ratings of Classroom Behavior are shown. 
TABLE 2 
Teachers' Global Ratings of 
Classroom Behavior - Percentage Change 
Treatment Group 
Behavior 
Rating Imipramine Methylphenidate Modification 
Much Worse 0 0 0 
Little Worse 0 0 11 
Unchanged JO 20 56 
Improved 40 JO JJ 
Much Improved JO 50 0 




As indicated, 70% of the imipramine subjects and 80% of 
the methylphenidate subjects were rated as improved or much 
improved, while JJ% of the behavior modification subjects 
were improved, with none being much improved. Specifically 
contrasting the two pharmacological groups, in the category 
of much improved, methylphenidate is favored to imipramine, 
with 50% of the methylphenidate subjects as compared to JO% 
of the imipramine subjects showing exceptional improvement. 
Percentage change data for the remaining categories of 
behavioral and academic improvement as rated by teachers 
are contained in Appendices S and T, respectively, with 
similar patterns evident. 
For each of the treatment groups, intercorrelations of 
change scores from the behavior rating scales, change scores 
from the psychological test battery, and the global ratings 
of improvement are contained in Appendix U. Upon inspec-
tion, the only discernible pattern appears to be the 
superiority of the methylphenidate group both in terms of 
the number and the directional consistency of the correla-
tions. In reference to the latter, for example, for the 
behavior modification group, an increase in Conduct Dis-
turbance on the School Report was directly related to an 
improvement on the Porteus Maze Test Age; for the imipramine 
group, a positive change in the WISC Full Scale score was 
negatively related to the teacherst global ratings of Class-
room Behavior. Considering the overall pattern of 
correlations, such directional inconsistencies were much less 
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It was the aim of the present study: to compare the 
effectiveness of pharmacological and behavioral therapies 
in the short-term, clinical treatment of minimal brain 
dysfunction; and, to compare the effectiveness of stimulant 
(methylphenidate) and antidepressant (imipramine) drugs 
in the short-term, clinical treatment of minimal brain 
dysfunction. 
Twenty-nine boys, ranging in age from 6 through 12 years, 
with the diagnosis of minimal brain dysfunction with hyper-
activity, were randomly assigned to three treatment groups: 
imipramine (N = 10); methylphenidate (N = 10); or behavior 
modification (N = 9), The total time of treatment for each 
child was 6 weeks. 
For subjects within the imipramine and methylphenidate 
groups, medication dosage was individually titrated by a 
child psychiatrist. (Range: 75-150 mg/daily of imipra-
mine, 10- JO mg/daily of methylphenidate,) 
Parents of subjects within the behavior modification 
group individually met with an experimenter 1 hour per week. 
Behavioral principles were discussed, problem behaviors tar-
geted, and behavioral programs devised for implementation 
during the treatment period. 
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Subjects assigned to the behavior modification were also 
individually seen once weekly. The first part of a session 
focused on behavioral control, following the method of 
behavior rehearsal. The second part was devoted to cogni-
tive control, with training in self-directed verbal 
commands instituted. 
For all groups, prior to and following treatment, 
behavioral and cognitive measures were obtained: parents 
completed the Parent's Questionnaire, a behavior rating 
scale; teachers completed the School Report, assessing 
behavior and academic achievement; and subjects were admin-
istered a battery of psychological tests which included the 
Wechsler Intelligence Scale for Children, Wide Range 
Achievement Test, Porteus Maze Test, Bender Gestalt Test, 
Developmental Test of Visual-Motor Integration, and Draw-A-
Person. 
Data were treated by analysis of variance and analysis 
of covariance procedures. Preplanned orthogonal contrasts 
were constructed comparing the average of the pharmacologi-
cal treatments with the behavioral treatment, and comparing 
imipramine treatment with methylphenidate treatment. When 
indicated, the Newman-Keuls technique was applied to assess 
pairwise contrasts of imipramine versus behavior modifica-
tion, and methylphenidate versus behavior modification. 
The specific hypotheses to be tested were: 
Hypothesis 1 
Behavioral treatment does not differ from two types of 
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pharmacological treatment (imipramine and methylphenidate) 
in its effects upon: 
a. selected behaviors, as measured by parents' and 
teachers' ratings, of MBD children. 
b. selected areas of cognitive functioning, as mea-
sured by teachers' ratings and psychological 
testing, of MBD children. 
Hypothesis 2 
Imipramine does not differ from methylphenidate in its 
effects upon: 
a. selected behaviors, as measured by parents' and 
teachers' ratings, of MBD children. 
b. selected areas of cognitive functioning, as mea-
sured by teachers' ratings and psychological 
testing, of MBD children. 
Results 
Prior to the consideration of the data as they bear upon 
the research hypotheses and the conclusions thus drawn, it 
is first necessary to consider the results in terms of the 
bounds of the design and the measurements themselves. 
Behavioral Measures 
Parent variables. Between the pharmacological and 
behavioral treatments, and between imipramine and methylphe-
nidate, no significant difference was found based on any of 
the factors from the Parent's Questionnaire. 
Given samples of 10, 10, and 9 subjects, in viewing the 
lack of significance between groups, one of the primary 
81 
considerations must be statistical power. With sample sizes 
this small, the power of the statistical tests may be so 
limited as to fail to detect differential treatment effects. 
Without the benefit of an untreated or placebo control 
group, it is also not possible to assess the absolute 
effectiveness of the treatments, only their relative effec-
tiveness. As indicated in the review of the treatment 
literature, Chapter 2, there are a number of studies, based 
on the criteria of parents' reports, attesting to the 
superiority of stimulant as compared with placebo treatment. 
However, as also indicated, while this superiority is most 
apparent when the results of several studies are considered 
together, it has not necessarily been a consistent finding 
in each individual study. Thus, statistical power aside, 
without an established baseline and lacking control data, 
the lack of differential treatment effects could plausibly 
indicate that the treatments resulted in equal deteriora-
tion, lack of effect, or improvement. 
A further point may be noted concerning the validity of 
parents' ratings. In one respect, in support of such 
ratings, it is contended that the person usually charged 
with the rating, the mother, is exposed to a more adequate 
sampling of behavior than is available in the laboratory or 
to the clinician (Weiss, Werry, Minde, Douglas, & Sykes, 
1968), However, in another respect, it has also been con-
tended that the relationship between parents' ratings and 
behaviors actually observed in the home is limited, and that 
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in a wish to please the clinician, there is likely to be a 
bias toward improvement in reports by parents (Patterson, 
1971). Thus, in addition to considerations of statistical 
power or options of equal deterioration, lack of effect, 
or improvement, it is also possible to hypothesize that 
the lack of differential treatment effects based on parents' 
ratings may be due to the lack of validity of the ratings 
per se. 
Teacher variables. From the School Report, based on 
teachers' factor ratings, no significant difference was 
obtained between pharmacological and behavioral treatments; 
between imipramine and methylphenidate treatments, of the 
four factors of the School Report, the only differential 
effect suggested (significant at the .10 level) was on the 
Hyperactivity factor. 
As with the parents' ratings, lack of significant group 
differences based on teachers' factor ratings may possibly 
be a reflection of power limitations of the statistical 
tests, equal efficacy of the treatments, or validity of the 
measurements. Interpretations beyond this, based solely on 
the factor scores, are limited. 
There were, however, significant differences between 
pharmacological and behavioral treatments, and differential 
effects were again suggested between imipramine and methyl-
phenidate, based on teachers' global ratings of behavior. 
It is not necessarily uncommon to find that differences 
based on global ratings are significant, while more 
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discrete ratings fail to distinguish between treatments. 
Specifically in relation to pharmacological treatment 
effects, Werry (1970) indicates that due to the multi-
variate and multisituational nature of the responses, the 
less atomistic measure has the advantage of reducing error 
variance, and thus increases the chance of observing dif-
ferential effects. 
Cognitive Measures 
Teacher variables. Based on teachers' global ratings 
of academic achievement, in the category of Spelling, a 
significant difference between pharmacological and 
behavioral treatments was indicated, and a differential 
effect was suggested in the category of Arithmetic. 
Between imipramine and methylphenidate, differential treat-
ment effects were suggested in both Spelling and Arithmetic 
categories. 
The differential treatment effects indicated or sug-
gested on the basis of teachers' ratings, however, were not 
evidenced on the basis of the Wide Range Achievement Test. 
Again, this is not necessarily unexpected; global ratings 
may be more sensitive to treatment effects, and, as 
indicated below, time may be a crucial factor in the mani-
festation of improvement based on traditional test measures. 
Subject variables. From the measures of the psychologi-
cal test battery, the only significant differences between 
pharmacological and behavioral treatments were obtained on 
the Object Assembly subtest of the WISC and the Porteus Maze 
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Qualitative Score. Between imipramine and methylphenidate, 
there was a suggestion of differential effects based only 
on the Draw-A-Person. 
In regard to the use of psychological tests as criteria, 
several points may be noted. Reviewing the general subject 
of testing and drugs, Baker (1968) reports that few, if 
any, changes based on the traditional measures of intellec-
tual, visual-motor, and academic functioning were found as 
a result of pharmacological treatment. Baker indicates 
that while, in one respect, subject variability may mask 
treatment effects, in another respect, the limits of 
testing may not have been appreciated; the implicit assump-
tion is that the traditional tests are sensitive to 
treatment effects, but this may not be. Especially appli-
cable to research with MBD children, as indicated in the 
reviews of the literature, Chapters 1 and 2, neither the 
cognitive deficits of the population nor the cognitive 
effects of the drugs are fully understood. Thus, one does 
not even know what, if anything, exactly to expect in terms 
of altered test performance. Even if treatment were to 
lead to improvement in the specific functions tapped by 
testing, it may be that time is needed for this cognitive 
improvement to develop; given short-term treatment, post-
testing intervals may not provide an adequate period of 
time for this improvement actually to have occurred or to be 
great enough to be reflected in test performance (Alexandris 
& Lundell, 1968). 
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Turning from the nonsignificant results on the majority 
of psychological tests to those tests on which differences 
were found (Object Assembly and Porteus Maze) or suggested 
(Draw-A-Person), it should be noted that in total, there 
were some 41 criterion variables designated in the study. 
Given the multiple analyses of variance and covariance com-
puted and the multiple contrasts performed, results must be 
qualified with a consideration of the number of Type I 
error possibilities. Such qualification is especially 
relevant in assessing the results from the Object Assembly 
subtest and the Draw-A-Person. Upon consideration, there 
appears to be nothing unique in either of these measures to 
suggest a specific sensitivity to treatment effects that 
would not also be reflected in some of the other measures. 
The Porteus Maze Test, in contrast, is considered a more 
discrete measure, with the Qualitative Score especially sen-
sitive to impulsivity. As indicated in Chapter 2, the test 
has in several studies been found to distinguish between 
placebo and stimulant drug groups. Thus, somewhat more con-
fidence is placed in the differential effect between pharma-
cological and behavioral treatments based on this measure 
than in the results based on either the Object Assembly 
subtest or Draw-A-Person. Without replication, in regard to 
the latter measures, Type I error must be strongly 
considered. 
Type I error considerations also enter into the interpre-
tation of heterogeneity of regression as found on the 
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Vocabulary subtest of the WISC, and also on the behavioral 
measures of Anxiety and Antisocial Behavior on the Parent's 
Questionnaire. The suggestion of interaction based on 
Vocabulary performance, with posttreatment scores for 
methylphenidate and behavior modification above those for 
imipramine within the lower ranges of pretreatment scores, 
is particularly interesting, for both methylphenidate and 
behavior modification treatments are, in a way, linked with 
deficient language development: methylphenidate in that it 
has been found to increase speech productivity (Creager & 
Van Riper, 1967); and behavior modification in that 
verbally mediated self-control training is theoretically 
based on an assumption of interrupted or incomplete 
language development (Palkes et al., 1968). Again, without 
replication, interpretations of interaction on the Vocabu-
lary subtest, or on the Anxiety and Antisocial Behavior 
factors, are limited, and further research is needed. 
Conclusions 
Hypothesis la 
Hypothesis la of the equal effects of pharmacological and 
behavioral treatments on the behavior of MBD children was 
not supported. Data from teachers' global ratings of Class-
room Behavior, Overall Behavior, Group Participation and 
Attitude toward Authority indicated the superiority of 
pharmacological treatment in comparison with behavioral 
treatment. Isolating specific group effects, on the basis 
of postmortem contrasts, contributing to the major portion 
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of the variance between treatments on the global ratings 
was the superiority of methylphenidate to behavior modifi-
cation; in only one category, Group Participation, was the 
superiority of imipramine to behavior modification 
indicated. It is thus felt that further research is needed 
before conclusions as to the therapeutic comparability or 
lack of comparability of the behavioral effects of imipra-
mine and behavior modification treatments are posited. 
Due to the necessities of time and personnel, the 
behavioral treatment devised did not include direct work 
with teachers, but focused instead upon direct work with 
parents and children within the clinic setting. Three of 
the parents, with the experimenters' approval, did contact 
teachers to arrange for circumscribed token programs within 
the classroom; for the remaining six behavior modification 
subjects, no such school involvement was instituted, and 
for two of these six subjects, the behaviors targeted by 
parents were in no apparent way related to school concerns. 
Thus, since for the majority of subjects within this group, 
direct school involvement was not instituted, conclusions 
as to the therapeutic efficacy of the behavioral treatment 
based on the School Report may, in fairness, be questioned. 
Comparative studies, as Patterson (1971) indicated, 
should consider the efficiency as well as the efficacy of 
treatments. Using the criterion of efficiency, pharmacolog-
ical treatment does appear to be a superior short-term, 
clinical treatment in comparison with the behavioral 
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treatment as devised for the present study. Without 
separately targeting individual behaviors, and without con-
cerns of setting specificity, pharmacological treatment, 
with a smaller professional investment, resulted in a wider 
spectrum of action than did the behavior treatment; that 
is, without specifically targeting such change, treatment 
effects at least equal to and at times superior to behavior 
modification were obtained in home behavior and school 
behavior, and also cognitive performance, at a cost of 
fewer professional hours with imipramine and methylpheni-
date treatments. 
Hypothesis lb 
Hypothesis lb of the equal effects of pharmacological 
and behavioral treatments on the cognitive functioning of 
MBD children was also not supported. Based on teachers' 
global ratings of Spelling achievement, pharmacological 
treatment was again shown to be superior to the behavioral 
treatment. The postmortem contrast between methylphenidate 
and behavior modification was significant, but not between 
imipramine and behavior modification. With reference to 
the latter groups, further research is again needed before 
conclusions as to the comparability or lack of comparabil-
ity of effects on the basis of Spelling achievement are 
indicated. 
The superiority of pharmacological treatment to 
behavioral treatment was also evidenced on the basis of the 
Porteus Maze Qualitative Score. From pretreatment to 
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posttreatment, for the behavioral treatment group, there 
was, in fact, an increase in cognitive impulsivity as mea-
sured by the Qualitative Score. As the postmortem contrasts 
of imipramine versus behavior modification and methylpheni-
date versus behavior modification were not significant, 
further research is indicated in regard to the differential 
effect of the individual drugs in comparison with behavioral 
treatment on the Maze test. 
Hypothesis 2a 
Hypothesis 2a concerned the equal effects of imipramine 
and methylphenidate treatments on the behavior of MBD 
children. Based on data from teachers' factor ratings of 
Hyperactivity and teachers' global ratings of Group Parti-
cipation and Attitude toward Authority, differences between 
imipramine and methylphenidate were significant at the .10 
level. Across factor ratings, with the exception of 
Anxiety, and across global ratings, the pattern of group 
means was consistent, with methylphenidate favored in com-
parison with imipramine. The comparability of the 
behavioral effects of imipramine and methylphenidate is thus 
in question, with the need for further research, with 
control and double-blind procedures in effect, definitely 
indicated. 
Hypothesis 2b 
Hypothesis 2b concerned the equal effects of imipramine 
and methylphenidate treatments on the cognitive functioning 
of MBD children. Again, across teachers' global ratings of 
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academic achievement, the pattern of group means was con-
sistent, with methylphenidate favored in comparison with 
imipramine; the group differences were significant at the 
.10 level in the categories of Spelling and Arithmetic. 
Thus, the comparability of imipramine and methylphenidate 
treatments in terms of cognitive effects is also in 
question, and further research is indicated within the cog-
nitive as well as the behavioral area. 
Application and Research Implications 
In terms of the short-term, clinical treatment of MBD 
children, the data and intercorrelations of scores from 
behavioral and cognitive measures have shown pharmacological 
therapy to be a more efficient mode of treatment, in terms 
of the breadth of the effects obtained and the professional 
time invested, than the behavioral procedure as implemented 
in the present study. Efficiency, of course, is an 
important consideration in the treatment of the multiple 
problem MBD child, especially when a situation has become 
such as to necessitate crisis intervention. Thus, the sug-
gestion as to the lack of comparability of pharmacological 
and behavioral treatments in this respect is of significance, 
and warrants further investigation under controlled and 
blind procedures. 
Efficiency, however, while a major consideration in the 
evaluation of treatments, is not the only consideration, and, 
at times, may even be a somewhat irrelevant consideration. 
It is not applicable in cases when the child is a 
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nonresponder to the medication. With reference to the 
present study, based on teachers' global ratings, as high 
as 40% and 60% of imipramine subjects, and 20% and 30% of 
methylphenidate subjects, were rated as unchanged in 
various categories of behavior and academic achievement, 
respectively. Efficiency, also, in no way relates to those 
instances in which a child's medical status precludes phar-
macological treatment, or when his reaction is so adverse 
as to necessitate a discontinuance of the treatment; it 
does not answer the question of the long-term influence of 
drugs on development; and it is unlikely to satisfy objec-
tions as to the increasing reliance on biochemical 
manipulation as a means of coping with problem behaviors. 
The usefulness of a non-drug, behavioral treatment cannot 
be assessed, therefore, solely by the criterion of 
efficiency. 
The few follow-up studies available, as reviewed in 
Chapter l, do suggest that behavioral and cognitive diffi-
culties continue into the teen years even for those MBD 
children previously treated pharmacologically. Wiens and 
Anderson (1971) conclude on the basis of follow-up data now 
available that the concomitant application of psychological 
and pharmacological treatments appears imperative. The 
limited research available on the combination of behavioral 
and drug treatment does indicate that concomitant applica-
tion of procedures results in a greater reduction of 
hyperactivity than does either procedure in itself (Sprague 
L 
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& Christensen, 1972). There is also the suggestion from 
work by Conrad and Insel (1967) and Weiss et al. (1971) 
that the effectiveness of pharmacological treatment is 
related to the quality of the parent-child relationship; 
thus, as Cantwell (1972) indicates, there is need for pro-
fessionals to include consideration of this relationship 
in the plan of treatment for the MBD child. It is apparent, 
then, that there is sufficient reason and considerable need 
for continued research into the application of behavioral 
programs with MBD children, both independent of and in con-
junction with pharmacological treatment. 
Pragmatically, as is now the case, it is likely that a 
substantial number of MBD children will continue to be 
referred to clinics; and given the limitations of personnel 
and time, behavioral treatment, whether alone or in 
combination with pharmacological treatment, will continue 
to be clinic-based for a portion of these children. Even 
when school-based programs are a possibility, again prag-
matically with limitations of personnel, time, and funding, 
it is likely that many such programs will not be able to 
approach the procedural sophistication with regard to 
apparatus and personnel of much of the behavioral research 
as reported in the literature. It is felt that suggestions 
are provided by the present study as to the clinic-based 
and, to a limited extent, the school-based implementation of 
behavioral programs. Although it was not possible to 
isolate statistically the components of the behavior 
L 
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modification treatment, it was the author's impression that 
some aspects of the treatment more than others appear to 
offer promise. 
The work directly with the behavior modification subjects, 
focusing on behavioral control, did not appear to be espe-
cially beneficial. In listening to the tape recordings of 
the sessions, it was the author's impression that for the 
majority of subjects, the discussion and rehearsal of behav-
iors were difficult; subject-initiated verbalizations were 
limited, and responses in answer to or at the suggestion of 
the experimenter were likewise meager. Behavior rehearsal 
had been reported by Gittelman (1965) to be a useful tech-
nique in the modification of impulsive and aggressive 
behaviors. Gittelman's subjects were older (12 to 13 years) 
than the subjects of the behavior modification group, and 
age may have been a factor in the difficulties encountered 
with the behavior rehearsal procedure in the present study. 
It has also been suggested by Pollack (1968) that, given the 
language deficits of many MBD children, a procedure heavily 
reliant on speech, as was the behavioral control training, 
may be more successful with groups other than MBD children. 
Using the criterion of Porteus Maze performance, the cog-
nitive control training with behavior modification subjects 
was not found to be an effective procedure. Results, thus, 
did not support the findings of the Palkes et al. (1968) 
study, which had reported a reduction in impulsivity using a 
similar verbally mediated procedure with the Porteus Maze as 
l. 
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the criterion. What specific factors may have contributed 
to the discrepancy between studies, such as time, tasks, or 
reinforcement procedures, warrant further research before 
such training can be considered a viable treatment tech-
nique. Process measures of time and errors during training 
would be beneficial in determining whether a reduction in 
impulsivity had, in fact, been obtained, but had failed to 
generalize across tasks or time. It has been suggested 
that simple delay training may be a necessary but not suf-
ficient condition for sustained reflective responding 
(Siegelman, 1969; Zelniker, Jeffrey, Ault, & Parsons, 1972). 
What may be needed is explicit training in attention deploy-
ment or search strategy rather than just in tempo; without 
the correction of strategy, delay alone may only lead to 
increased distractibility. 
In reference to the training sessions with parents, based 
solely on parents' reports as there were no direct home 
observations, there appeared to be a wide variability in the 
degree and consistency with which programs were actually 
implemented. It was the author's impression that the suc-
cess of the procedure, as reported by parents, was directly 
related to the extent and quality of the implementation. 
That parents do vary in their willingness and/or ability to 
implement programs, and that success is dependent upon 
implementation rather than discussion, is certainly not sur-
prising, and has been reported by other investigators 
(Patterson & Gullion, 197la; Salzinger, Feldman, and Portnoy, 
L 
1970). In the interest of furthering such implementation, 
as also indicated by these investigators, it is suggested 
that the observation and recording of behavior by parents 
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be made definite requirements of the training, and that 
provisions be included in the program for the experimenter's 
cueing or modeling of techniques, and when necessary, his 
direct intervention with the child in the home and/or 
clinic setting. 
While there are reports in the literature of limited 
generalization of behavioral change from home to school 
(O'Leary et al., 1967), it has more generally been found 
that home and school settings are functionally independent 
(Wahler, 1969b). Certainly, the preferred strategy in 
obtaining classroom improvement is to work specifically 
within the school setting, involving teachers, peers, and 
parents in the behavioral program (Patterson et al., 1969), 
Within the context of the present study, when parents did 
arrange for circumscribed programs within the classroom, it 
appeared that the likelihood for improvement in the 
behaviors so targeted was increased. For example, with a 
daily note sent home contingent upon one subject's comple-
tion of arithmetic, it was found that on the Follow-Up 
School Report the teacher had rated Arithmetic achievement 
as improved although other behavioral and academic 
categories were rated unchanged or worse. Thus, even though 
treatment may originate in the clinic, if school behaviors 
are of concern, it is suggested that efforts, whenever 
L 
96 
possible, be made for the implementation of behavioral 
programs directly within the school setting. It may be 
noted that in regard to other possible predictors of either 
behavioral or academic change, examining the relationship 
between pretreatment measures and teachers' global ratings 
for the behavior modification subjects, no stable pattern 
of intercorrelations was obtained. 
With reference to behavioral procedures, one further 
consideration is offered. The treatment interval of the 
present study was limited to 6 weeks for all groups. While 
this is within the traditional time period of short-term 
pharmacological research, the 6-week interval, with one 
session per week, falls at the lower end of the 5 to 15 
weekly sessions Patterson and Gullion (l97la) have found to 
be necessary for parents to obtain adequate behavioral con-
trol, and below the 8 to 10 sessions recommended even when 
direct classroom intervention procedures, with instrumenta-
tion, are in use (Patterson et al., 1969). In terms of 
research and implementation of behavioral procedures with 
MBD children, it would thus be suggested that the time 
allotted for behavioral treatment, even when in conjunction 
with pharmacological treatment, be extended, determined by 
the behavioral model in effect. 
Sessions 
l & 4 
2 & 5 




Trail Making Test: 
Part A 
Columbia Mental Maturity Scale: 
Items l-J9, 42, 4J, 4?, 48, 50, 51, & 57 
Illinois Test of Psycholinguistic 
Abilities: 
Visual Closure - D, l, & 2 
Trail Making Test: 
Part B 
Leiter International Performance Scale: 
Items V-2, VI-2, & VI-4 
Illinois Test of Psycholinguistic 
Abilities: 
Visual Closure - J & 4 
Frostig FG: 
Exercises 10, 15, & 19 
Leiter International Performance Scale: 
Items VIII-2, IX-J, & X-2 
Children's Embedded Figures Test: 
Tent Series (session J) 
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Command and Reinforcement Procedures for 
Cognitive Control Training. 
During sessions 1 through 4, the subjects verbalized 
aloud the commands printed on the visual reminder cards 
prior to responding to any subpart of a task: Card 1 for 
trail making tasks from the Trail Making Test (Reitan, 
1955) and the Frostig Program for the Development of 
Visual Perception (Frostig & Horne, 1964); Card 2 for 
matching pictures from the Columbia Mental Maturity Scale 
(Burgemeister, Blum, & Lorge, 1959) and the Leiter Inter-
national Performance Scale (Leiter, 1948); and Card 3 for 
embedded figures from the Illinois Test of Psycholinguis-
tic Abilities (Kirk, McCarthy, & Kirk, 1968) and the 
Children's Embedded Figures Test (Karp & Konstadt, 1971). 
During sessions 5 and 6, self-directed commands were 
read silently. 
For each response correct upon initial attempt during 
sessions 1 through 3, subjects received a poker chip, 
later exchanged for M&M candies. 
During sessions 4 and 5, poker chips were dispensed on 
an FR 3 schedule of reinforcement. 
During session 6, no chips were dispensed during the 
performance of training tasks, but upon the completion of 
the session, subjects were reinforced based on the experi-




Week Day Assignment 
I. 1 Trail Making 
2 Frostig FG: Exercise 22 
3 Frostig FG: Exercise 23 
4 Frostig PS: Exercise 24 
5 Frostig FG: Exercise 21 
6 Frostig PS: Exercise 23 
II. 1 Frostig FG: Exercise 16 
2 Frostig PS: Exercise 7 
3 Frostig PS: Exercise 6 
4 Frostig PS: Exercise 3 
5 Frostig FG: Exercise 17 
6 Frostig FG: Exercise 25 
III. 1 Frostig PS: Exercise 22 
2 Frostig FG: Exercise 37 
3 Highlights Hidden Pictures 
4 Frostig PS: Exercise 10 
5 Frostig FG: Exercise 40 
6 Highlights Hidden Pictures 
IV. 1 Highlights Hidden Pictures 
2 Frostig FG: Exercise 27 
3 Frostig FG: Exercise 63 
4 Highlights Hidden Pictures 
5 Frostig FG: Exercise 44 
6 Frostig FG: Exercise 60 
v. 1 Highlights Hidden Pictures 
2 Frostig FG: Exercise 39 
3 Frostig FG: Exercise 41 
4 Highlights Hidden Pictures 
5 Frostig PS: Exercise 4 
6 Frostig FG: Exercise 62 
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Bragging and boasting 
Sassy to grown-ups 
Mean 
Fights constantly 
Picks on other children 
Blames others for his mistakes 
Afraid of new situations 
Afraid of people 
Afraid of being alone 
Worries about illness and death 
Shy 
Afraid others do not like him 
Is afraid to go to school 
Inattentive, easily distracted 
Constantly fidgeting 
Cannot be left alone 
Always climbing 
A very early riser 
Will run around between mouthfuls at meals 
Unable to stop a repetitive activity 
Acts as if driven by a motor 
Has no friends 
Is not learning 
Does not like to go to school 
Will not obey school rules 














APPENDIX E (continued) 
Observation 
Everything must be just so 
Things must be done same way every time 
Sets goals too high 
Stealing from parents 
Stealing at school 
Stealing from stores and other places 
Gets into trouble with police 
Gets stiff and rigid 
Twitches, jerks, etc. 
Shakes 




Reliability and Validity Data for the Parent's Questionnaire 
Development of the Parent's Questionnaire (Conners, 1970) 
was based on data from a study with hyperkinetic, neurotic, 
and normal children, the purpose of which was to determine 
whether parent ratings of symptomatology could serve to dis-
tinguish among the groups. 
Subjects ranged in age from 5 to 16 years. The clinical 
sample consisted of 166 hyperkinetic and 137 neurotic 
children seen at an outpatient psychiatric clinic. The nor-
mal sample consisted of 365 children attending public 
schools, with any child with a psychiatric history or known 
adjustment problem excluded. 
Parents of all subjects completed a ?J-item symptom 
rating scale. Information concerning the reliability of the 
ratings was not provided. 
The data were treated by rotated principal components 
factor analyses, resulting in six factors: aggressive con-
duct disorder; anxious-inhibited; antisocial; enuresis; 
psychosomatics; and anxious-immature. 
Between patient and control groups, there appeared to be 
general agreement in the general factor structure of 
symptomatology, but the severity of symptomatology was 
higher for the hyperkinetic and neurotic subjects. 
Between hyperkinetic and neurotic groups, significant 
differences in severity were indicated on factors of 
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aggressive conduct disturbance, antisocial, and enuresis, 










School Report Observations 
Observation 






Temper outbursts, explosive and 
unpredictable behavior 







Inattentive, easily distracted 
Fails to finish things he starts -
short attention span 
Daydreams 
Appears to be easily led 
Appears to lack leadership 
Overly sensitive 




(-) Attendance problem 
Constantly fidgeting 
Hums and makes other odd noises 
Restless or overactive 
Excitable, impulsive 
Disturbs other children 
Teases other children or interferes 
with their activities 
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Reliability and Validity Data for the School Report 
Development of the School Report (Conners, 1969) was 
based on data from a pharmacological study of dextroamphe-
tamine and placebo treatment of children with behavior 
disorders, hyperactivity, or poor attention spans associated 
with learning problems. 
The sample consisted of 82 boys and 21 girls, with a mean 
age of 117.5 months, referred to an outpatient psychiatric 
clinic. 
Prior to and during the last week of a J-week treatment 
period, teachers completed a 39-item rating scale. Frequen-
cy distributions indicated that each of the items was 
responded to at least 10 per cent of the time, and thus all 
were retained for further analysis. 
The pre-drug questionnaires were subjected to a rotated 
principal components factor analysis, and resulted in five 
factors: aggressive conduct disorder; daydreaming-
inattentive; anxious-fearful; hyperactivity; and a poorly 
defined sociability factor. The highest loaded items on 
each factor were retained to give factor-based scores. 
An indication of the reliability of the scale was 
provided by the correlations, ranging from .72 to .91, 
between pre- and posttreatment scores for the placebo group; 
for the drug group, pre - post correlations ranged from .6) 
to • 71. 
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Drug and placebo groups did not differ on any factors 
before treatment. Pre- to posttreatment change scores were 
computed for each group, and the net differences between 
groups were evaluated by t tests. Results indicated signi-
ficant changes with drug treatment on all five factors, as 
compared with the changes in placebo scores. 
Inasmuch as changes with drug treatment had been con-
firmed by objective measures and other forms of rating 
(although these were not elaborated), it was concluded that 






Analysis of Covariance Summary Table for Parent's Questionnaire Factor Ratings 
Source df Source df 
l/2 (I+ M)- B l I-M l 
Factor Error 24 Error 24 
MStreat MS F MS MS F error treat error 
Conduct Disturbance 115 8178 101 5~59 8178 .6J 
Anxiety 1.79 l. 95 .91 .29 l. 9.5 .15 
Hyperactivity 4.92 19.17 .25 .L~o 19~17 I 02 
Learning Problem ~lJ 2.91 104 J.9l 2~91 l~J4 
Somatic Complaints J.5l J.J? l. 04 100 J.J7 .00 
Obsessional Traits 2.49 J.l8 178 6.46 J.l8 2. OJ 
' 
Antisocial Behavior .4J .15 2186 .28 115 1.86 
Muscular Tension 2.88 2.52 1.14 . 09 2~52 . OJ 







Analysis of Covariance Summary Table for School Report Factor Ratings 
Source df Source 
1/2 (I+ M)- B 1 I-M 
Error 25 Error 
Factor MS MS F MS MSerror treat error treat 
Conduct Disturbance 61.91 JJ.63 l. 84 38.98 JJ,63 
Distractibility 15.64 9.11 l. 71 7.75 9.11 
Anxiety .09 J. 07 .OJ .77 J,O? 























*,~,\- p . 01. ,, ,_ ,, ,, < OOl 
x-."'"i<' P<· -· 
Source 
























MS MS treat error 
.45 .60 
l. 25 . 79 
l. 25 .Jl 
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Pairwise Contrasts of Imipramine versus Behavior 
Modification and Methylphenidate versus Behavior 
Modification for the Teachers' Global Ratings of Behavior 
(Newman-Keuls Technique) 
Critical Value 
Category s "" = .05 YI- YB m 1 rank separation 
Classroom .24 .79 .77 
Behavior 
Overall .28 .91 .68 
Behavior 
Group .18 .57 . 71 * 
Participation 
Authority .JJ l. 07 .72 
Attitude 
Critical Value 
Category s a( = . 05 YM- YB m 2 ranks separation 
Classroom .24 .98 1. 07 * 
Behavior 
Overall .28 1.13 1.18 ~l-
Behavior 
Group .18 .71 1. 21 * 
Participation 
Authority ·33 l. 33 1. 62 ~l-
Attitude 












** .P<. 05. 
Source 
l/2 (I+ M) - B 
Error 




df Source df 
l I-M l 
26 Error 26 
F MStreat MS F error 
l. 25 .80 .58 l. J6 
5.85 ~H~ 1.25 .41 2. 99 ~~ 
J. 08 ~~ 1.80 .46 J. 91 ~~ 
APPENDIX N 
Pairwise Contrasts of Imipramine versus Behavior 
Modification and Methylphenidate versus 







1~ P<· 05. 
Global Ratings of Academic Achievement 
(Newman-Keuls Technique) 
Critical Value 
sm ~ = .05 




sm d--. = . 05 
2 ranks separation 

















Full Scale I 
Information I 
















































































APPENDIX 0 (continued) 
Source 












































































APPENDIX 0 (continued) 
Source df 
1/2 (I+ M) - B 1 
Error 25 
Test MS MS F treat error 
PORTEUS MAZE 
Test Age 6.J8 J.18 2.00 
Qualitative Score 48?J.10 988.12 4, 9J ~H~ 
BENDER GESTALT 
Errors J.88 J.6o l. 07 
VMI 
Forms Passed .23 ?.J8 'OJ 
DRAW-A-PERSON 
Standard Score 11.81 so. 54 .2J 
* p<.lO. 























Adjusted Group Means and Standard Deviations 
for Behavior Factor Ratings 
Treatment Group 
Factor Behavior 
Imipramine Methylphenidate Modification 
.PARENT Is 
QUESTIONNAIRE 
Conduct M 5.8 6.8 6.4 
Disturbance SD 2.1 J.l J.4 
Anxiety M 2.9 J.2 2.5 
SD 1.0 1.6 1.5 
Hyperactivity M 8.4 8.1 ?.J 
SD 4.9 J.9 4.0 
Learning M J.2 2.J 2.6 
Problem SD 1.6 1.9 1.5 
Somatic M 1.5 1.5 2.J 
Complaints SD 1.5 1.9 1.9 
Obsessional M 2.6 1.4 1.4 
Traits SD 2.6 1.1 0.9 
Antisocial M O.J o.o 0.4 
Behavior SD O.J 0.2 0.5 
Muscular M 1.5 1.6 0.8 
Tension SD 1.5 2.1 0.9 
SCHOOL REPORT 
Conduct M 9.1 6.J 10.9 
Disturbance SD 6.0 4.5 6. Lj, 
Distractibility M 6.J 5.0 ?.2 
SD J.l 2.1 J.6 
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APPENDIX P (continued) 
Treatment Group 
Factor Behavior 
Imipramine Methylphenidate Modification 
Anxiety M 2.J 2.7 2.7 
SD 1.8 1.9 1.4 
Hyperactivity M 8.5 5.9 9.1 
SD J.O J.2 _3.4 
APPENDIX Q 






























Imipramine Methylphenidate Modification 
4.0 4.J J.2 
0.8 0.8 0.7 
J.8 4.J J.l 
0.8 0.8 1.0 
J.6 4.1 2.9 
0.5 0.6 0.6 
J.5 4.4 2.8 
1.2 0.8 1.1 
J.? 4.1 J.6 
0.8 0.6 0.9 
J.6 4·.1 J.2 
0.7 0.7 0 .I~ 
J.4 4.0 J.2 
0.5 0.8 0.'? 
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Adjusted Group Means and Standard Deviations 
for Psychological Test Variables 
Treatment Group 
Test Behavior 
Imipramine Methylphenidate Modification 
WECHSLER 
Verbal M 101.1 104.? 101.0 
SD 5.2 5.J 4.6 
Performance M 111.1 108.9 lOS.J 
SD 7.2 10.1 5. 4· 
Full Scale. M l06.J 107.3 105.1 
SD 6.0 7.6 4-.7 
Information M 10.2 10.4 9.6 
SD 1.2 1.6 l.J 
Comprehension M· 9.7 11.6 10.4· 
SD 1.7 J.4 2.0 
Arithmetic M 9.8 9.9 8.6 
SD 2.J 2.4 1.9 
Similarities M 10.4 11.5 ll. 9 
SD 2.9 2.7 J.O 
Vocabulary M 10.7 10.9 ll. 3 
SD 1.8 1.1 l.O 
Digit Span M 10.2 10.3 9.0 
SD 2.J 1.5 1.6 
Picture M 11.6 10.6 ll. 6 
Completion SD 1.8 2.8 2.0 
Picture M 12.5 12.5 11.0 



























































































































Teachers' Global Ratings of Behavior--Percentage Change 
Treatment Group 
Rating Behavior 
Imipramine Methylphenidate Modification 
Overall Behavior 
Much Worse 0 0 11 
Little Worse 0 0 11 
Unchanged 40 20 JJ 
Improved 40 JO 44 
Much Improved 20 50 0 
Group Participation 
Much Worse 0 0 0 
Little Worse 0 0 22 
Unchanged 40 10 67 
Improved 60 70 ll 
Much Improved 0 20 0 
Attitude Toward Authority 
Much Worse 0 0 0 
Little Worse 0 0 ll 








APPENDIX S (continued) 
Treatment Group 
Behavior 
Imipramine Methylphenidate Modification 
40 40 33 
0 30 0 
entries are percent of subjects in each treat-
APPENDIX T 




Imipramine Methylphenidate Modification 
Reading 
Much Worse 0 0 0 
Little Worse 0 0 0 
Unchanged 50 10 67 
Improved JO 70 ll 
Much Improved 20 20 22 
Spelling 
Much Worse 0 0 0 
Little Worse 0 0 0 
Unchanged 50 20 78 
Improved 40 50 22 
Much Improved 10 JO 0 
Arithmetic 
Much Worse 0 0 0 
Little Worse 0 0 ll 






APPENDIX T (continued) 
Treatment Group 
Behavior 
Imipramine Methylphenidate Modification 
40 40 JJ 
0 JO 0 




































Change Scores, Behavioral Change Scores, 
and Teachers' Global Ratings 
Variable Labels 
WISC - Full Scale 
WISC - Verbal 
WISC - Performance 
Wide Range - Reading 
Variable 
Wide Range - Spelling 
Wide Range - Arithmetic 
Porteus Maze - Test Age 




School Report - Conduct Disturbance 
School Report -Distractibility 
School Report - Anxiety 
School Report -Hyperactivity 
Teachers' Global Rating- Classroom Behavior 
Teachers' Global Rating- Overall Behavior 
Teachers' Global Rating- Group Participation 
Teachers' Global Rating- Authority Attitude 
Teachers' Global Rating- Reading Achievement 
Teachers' Global Rating- Spelling Achievement 
Teachers' Global Rating- Arithmetic Achievement 
Parent's Questionnaire Conduct Disturbance 
Parent's Questionnaire -Anxiety 
Parent's Questionnaire -Hyperactivity 
Parent's Questionnaire - Learning Problem 
Parent's Questionnaire - Somatic Complaints 
Parent's Questionnaire - Obsessional Traits 
Parent's Questionnaire - Antisocial Behavior 
Parent's Questionnaire -Muscular Tension 
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APPENDIX U (continued) 
Matrix of Significant Intercorrelations* 
Imipramine and Methylphenidate Groups 
l 2 3 4 5 6 7 8 9 10 ll 12 1:; 14. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
.8} .71 .75 -.78 -.66 
.70 ,65 
-.80 -.64 -.72 
-.86 -.77 ,64 ,64 -.71 







.J. -.75 ~ .76 -.66 .61 
14 -.67 
L:: 
lG .65 -.70 .64 -.80 -.74 .92 .64 .a, 
17 .76 -.71 -.68. -.68 -.73 .92 .64 .a, 
.65 -.69 .75 
-. 7l .69 I .72 
-.67 .66 -.84 
2 .• 64 -;.78 
.69 
-.77 -........_ .70 
?c --
2~ .66 -.68 
,68 ~. .81 
2' 




Note.--Correlations for the imipramine group are presented below the diagonal; correlations 
for the methylphenidate group above the diagonal. 





APPENDIX U (continued) 
Matrix of Significant Intercorrelations ~~ 
Behavior Modification Group 










lJ -.76 • 76 .89 
2C -.74 -.72 
21 -.67 -.69 
22 .71 
2) 
24 .72 .69 
~s 
2~ .n .n 
27 .69 
2:: .68 
~~.:. - .68 .75 .68 




* p <· 05. 
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